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ABSTRACT 
 
PURPOSE The primary purpose of this study was to determine the effect of 
ingesting an 8% carbohydrate (CHO) beverage during a moderate intensity exercise trial 
on performance outcomes, fuel utilization and blood glucose levels of wheelchair 
athletes (spinal cord injury (SC I) or cerebral palsy (CP)).  The secondary purpose was 
to analyze the dietary intake of the eight participants and to determine if they were 
meeting current sport nutrition guidelines for macronutrients and fluids recommended in 
the joint position statement developed by the American Dietetic Association (ADA), the 
American College of Sports Medicine (ACSM) and Dietitians of Canada (DC). 
METHODS Under random, double blind conditions eight athletes (6 males, 2 females); 
mean age 36 ± 8.5 y with a SCI (n = 7) or CP (n = 1) completed two exercise trials on an 
adapted stationary hand cycle; each trial was 60 minutes in duration at 65 % VO2peak 
followed immediately by a 30-minute performance trial. During the first 60-minutes the 
participants were given four 200 ml dosages (15, 30, 45, 60-min) of an 8% CHO 
beverage or a taste-matched placebo beverage. Blood lactate and glucose levels were 
sampled during the 60-minute exercise trial (pre, 20, 40, 60-min) and immediately after 
the 30-minute performance trial (post, 2, 5, 10-min). Heart rate was monitored 
continuously during the exercise and performance trial. Expired gas samples were also 
taken for 5-min periods during the exercise trial and then continuously during the 
performance trial. These values were used to calculate respiratory exchange ratio (RER) 
and carbohydrate oxidation. Dietary intake was assessed with a three day food record.  
RESULTS No significant differences were apparent between beverage trials for total 
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distance (km), average speed (km·hr-1) or maximum speed achieved (km·hr-1). 
Significant differences were evident for blood glucose values, RER and CHO oxidation 
between the two beverage trials (p< .05). At the end of the 30-minute performance trial 
blood glucose values were significantly higher in the CHO trial (4.8 ± 1.3 mmol.l-1 vs. 
4.0 ± 0.5 mmol.l-1 for placebo trial; p< .05). The CHO beverage resulted in higher CHO 
oxidation during the last 5 minutes of the performance trial, 2.1 ± 1.0 g·min-1 vs. the 
placebo beverage 1.9 ± 1.0 g·min-1 (p< .05). The CHO beverage trial resulted in 
significantly higher RER values during the final 5 minutes of the exercise trial and 
during the final 10 minutes of the performance trial. At the 20-25 minute mark RER 
values were significantly higher with the CHO beverage trial (1.04 ± 0.10) vs. the 
placebo trial (1.01 ± 0.11) (p< .05). During the final 5 minutes of the performance trial 
RER values were also significantly higher with the CHO beverage trial (1.06 ± 0.11) vs. 
the placebo trial (1.01 ± 0.10) (p< .05). The results indicated the participants were not 
meeting the current dietary guidelines for able-bodied athletes and active adults. Only 
25% of the participants met the daily caloric requirements for active adults. 
Carbohydrate recommendations of 6 to 10 g·kg-1 body weight·d -1 were not met by any 
of the wheelchair athletes Seven participants were within the acceptable macronutrient 
range (AMDR) for CHO. For protein intake, 63% of the participants were meeting the 
protein recommendations active adults and all of them were within the AMDR. Average 
caloric intake from fat exceeded current recommendations of 20 to 25%; two 
participants were above the AMDR. The results demonstrate that the 8% CHO beverage 
consumed during exercise resulted in higher CHO oxidation rates and elevated blood 
glucose values, but it did not result in a performance gain. 
iv 
 
Acknowledgements 
I would like to thank my supervisor Dr. Carol Rodgers for her continuing support and 
guidance throughout this research process. I would also like to thank my committee 
members: Dr. Phil Chilibeck, Mr. Bruce Craven and Dr. Gord Zello for their ongoing 
support during the planning and implementation process and with the written document. 
I would also like to thank my external examiner, Prof. Laura Klassen for her advice and 
during the final stages of the document. 
I would also like to acknowledge the Saskatchewan Academy of Sport Medicine for 
their funding support of this research project. Thank you very much to all of the 
participants that took part in my research study. 
I would also like to thank my family for their ongoing support and guidance during this 
research study. 
 
 
 
 
 
 
 
v 
 
TABLE OF CONTENTS 
PERMISSION TO USE                                                                     i 
ABSTRACT                                                                                        ii-iii 
ACKNOWLEDGEMENTS                                                               iv 
TABLE OF CONTENTS                                                                   v-viii 
LIST OF ABBREVIATIONS                                                            ix-x 
1. SCIENTIFIC FRAMEWORK 
 
1.1.1.  Introduction ……………………………………………………...1-3 
1.1.2. Research objectives and hypothesis………………………………3-4 
1.2.  Literature Review…………………………………………………...4-30 
1.2.1. Current recommendations for carbohydrate intake before and during 
exercise……………………………………………………............5-6   
1.2.2. Pre-exercise carbohydrate recommendations…………………… 6-11  
1.2.3. Carbohydrate recommendations during exercise………………..11-13 
1.2.3.1. Carbohydrate feeding late in exercise……………….13-14 
1.2.4. Carbohydrate composition consumed during exercise………….14-17   
1.2.5. Impact of gender on fuel use during exercise…………………...17-18 
1.2.6. Impact of carbohydrate intake on rating of perceived exertion…19-20   
1.2.7. Current dietary guidelines for able-bodied athletes……………..20-23 
1.2.7.1. Dietary assessment tools…………………………… 23-24 
1.2.8. Current research with wheelchair athletes………………………24-26   
1.2.9. Research conducted on fuel utilization with wheelchair athletes 26-30   
 
2. METHODS 
 
2.1.  Participants………………………………………………………….31    
2.2. Experimental design…………………………………………………33-42    
vi 
 
2.2.1. Details of anthropometric and body composition collection…..34-36 
2.2.2. Details of 3-day food and activity records…………………….36-37 
2.2.3. Protocol for the maximal oxygen uptake test (VO2peak)………37-38 
2.2.4. Protocol used for group assignments………………………….38 
2.2.5. Carbohydrate beverage protocol………………………………38-39 
2.2.6. Pre-exercise meal protocol…………………………………….40 
2.2.7. Expired gas collection and blood sample analysis……….........40-41 
2.2.8. Exercise and performance trial………………………………...42-43 
2.3. Statistical Analysis…………………………………………………43-44   
 
3. RESULTS  
 
3.1 Body composition………………………………………………………45 
3.2 Three day food records…………………………………………………45-46   
3.3 Maximal exercise measures…………………………………………….46 
3.4 Menstrual cycle timing…………………………………………………47 
3.5 Exercise trial physiological measures  
3.5.1 Respiratory exchange ratio…………………………………48  
3.5.2 Carbohydrate oxidation…………………………………….49 
3.5.3 Oxygen uptake……………………………………………...50 
3.5.4 Fat oxidation………………………………………………..52    
3.5.5 Heart Rate…………………………………………………..52  
3.6 Finger Tip Capillary Blood Analyses 
3.6.1 Blood glucose………………………………………………53  
3.6.2 Blood lactate……………………………………………......54 
3.7 Rating of perceived exertion……………………………………………54 
3.8 Exercise Performance Measures………………………………………..55-56 
 
 
 
vii 
 
4. DISCUSSION 
 
4.1 Participant characteristics……………………………………..57-61  
4.1.2 Participant’s body composition……………………….61-62 
4.2 Fuel use during exercise……………………………………....63-65 
4.3 Pre-exercise carbohydrate feeding regime……………………65-68   
4.4 Respiratory exchange ratio……………………………………68-73   
4.5 Carbohydrate oxidation during exercise ……………………..73-74   
4.6 Impact of CHO feeding on blood glucose values…………….75-77  
4.7 Impact of gender on fuel utilization…………………………..77-78 
4.8 Impact of CHO feeding on blood lactate values……………...78-80 
4.9 Oxygen uptake and heart rate values………………………….80-81  
4.10 Rating of perceived exertion………………………………….81-82 
4.11 The participants dietary intake………………………………..82-87   
4.12 Research Limitations………………………………………….87-89  
 
5 SUMMARY AND CONCLUSIONS 
5.1  Summary………………………………………………………90-91  
5.2 Conclusions……………………………………………………91-92 
5.3  Recommendations for Future Research………………………92-93 
 
REFERENCES...............................................................................................94-106 
LIST OF TABLES 
Table 1 and Table 2 - Participant Characteristics………………………………32  
Table 3 – Anthropometric and Body Composition Values……………………..45 
Table 4 – Three-Day Food Records……………………………………………46   
Table 5- Participant Resting Heart Rate Values and VO2peak Testing Values….47 
Table 6 – Physiological Values for the Exercise and Performance Trial………51  
Table 7- Blood Parameters and RPE…………………………………………...55  
viii 
 
 
LIST OF FIGURES 
Figure 1. Respiratory Exchange Ratio during Exercise and Performance Trial……..49 
Figure 2. Carbohydrate Oxidation during Exercise and Performance Trial…………50  
Figure 3. Heart Rate collected during Exercise and Performance Trial……………...53  
Figure 4. Blood Glucose collected during Exercise and Performance Trial…………54  
Figure 5. Distance results from 30-min performance trials………………………….56 
 
APPENDICES 
      Appendix I – Consent Form………………………………………………….107-112 
      Appendix II- Certificate of Research Ethics Board Approval……………….113 
      Appendix III- Medical and Health Participant Questionnaire and PAR-Q….114-116 
      Appendix IV- 3-Day Food and Activity Record……………………………..117-118 
      Appendix V- Experimental design diagram…………………………………..119 
      Appendix VI- Pre-Exercise CHO meal lists based on body weight (kg)……..120 
      Appendix VII- Individual Distance and %VO2peak values for the 60-min exercise 
trials and VO2peak values for the 30-min performance trials 
                                                                                                                                 121-122 
     Appendix VIII- Individual performance results (distance, average speed, max speed) 
for 60-min exercise and performance trials, individual RER, blood 
glucose (mmol.l-1) and blood lactate (mmol.l-1) results………123-136 
 
 
 
 
 
ix 
 
 
 
LIST OF ABBREVIATIONS 
 
AI- Adequate intake 
AMDR- acceptable macronutrient distribution range 
% BF- percent body fat 
BMC- bone mineral content 
BMD- bone mineral density 
BMI- body mass index 
Bpm- beats per minute for heart rate 
C- cervical 
Ca- Calcium 
CHO- carbohydrate 
CP- cerebral palsy 
DLW- doubly labelled water 
DXA- dual-energy x-ray absorptiometry  
FFA- free fatty acids 
FFM- fat free mass 
FS- feeling scale 
FP- follicular phase 
GI- glycemic index 
HG- high glycemic 
HR- heart rate 
x 
 
kcal- kilocalories 
LBM- lean body mass 
LG- low glycemic 
LP- luteal phase 
RDA- recommended dietary allowance 
REE- resting energy expenditure 
RPE- rating of perceived exertion 
RER- respiratory exchange ratio 
SCI- spinal cord injury 
T- thoracic 
TEF- thermic effect of food 
VE- minute ventilation 
VCO2- carbon dioxide output 
VO2- oxygen uptake 
VO2max- maximal oxygen uptake 
VO2peak- peak oxygen uptake 
WHO- world health organization 
 
CHAPTER 1 
 
1.1 INTRODUCTION 
 
 
The primary objective of this project was to determine the effect of ingesting an 8% 
carbohydrate (CHO) beverage during a moderate intensity exercise trial followed immediately 
by a 30-minute performance trial on performance, fuel utilization and blood glucose levels of 
wheelchair athletes1 with spinal cord injury or cerebral palsy. The secondary objective was to 
analyse the dietary intake of the eight participants to determine if they were meeting current 
able-bodied sport nutrition guidelines for macronutrient and fluid intake as recommended in 
the American Dietetic Association (ADA), American College of Sports Medicine (ACSM) 
and Dietitians of Canada (DC) Joint Position Paper Nutrition and Athletic Performance 
(ADA, ACSM, DC, 2000). 
During moderate to high intensity exercise, the body becomes dependent on 
carbohydrate as the primary fuel source for the working muscle tissue. Carbohydrate feeding 
delays the onset of fatigue and enhances exercise performance by sparing muscle glycogen 
(Coyle & Coggan, 1984). Carbohydrate feeding may also improve performance by preventing 
the exercise induced drop in blood glucose (Coyle, 1983). Blood glucose concentration 
depends on the balance between the rate of glucose entering the blood stream from the liver or 
digestive tract and the rate of glucose uptake by the active muscle tissue (Coyle & Coggan, 
1984). With prolonged exercise, without CHO feeding, blood glucose will drop due to 
increased demand and decreased supply. A drop in blood glucose leads to an increase in the 
secretion of the catabolic hormone glucagon, which increases glycogenolysis and 
gluconeogenesis for the prevention of hypoglycaemia.  
                                                 
1 The term wheelchair athlete will be used to describe the participants in the current study. Each 
participant competes at a national or provincial level within their specific sport. 
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Fuel utilization has been researched for several decades with able-bodied athletes.  
Specific CHO ingestion guidelines have been developed to ensure a feeding regime that will 
provide the body with a supplemental fuel source which can be oxidized in sufficient 
quantities to delay the onset of fatigue and spare any remaining muscle glycogen stores (Coyle 
& Coggan, 1984). However, research in the area of fuel metabolism during aerobic exercise in 
wheelchair athletes is relatively new and presents many unique physiological challenges. 
Specifically, athletes with a spinal cord injury (SCI) have a loss or impairment of both the 
sympathetic and parasympathetic responses (Spendiff & Campbell, 2005). These altered 
responses may impact the action of major organs and hormones that play a direct role in 
substrate metabolism and cardiovascular response to exercise (Cowel, Squires, & Raven, 
1990). Individuals with a SCI have an increased dependency on CHO utilization during 
exercise, with a decreased ability to utilize lipids as a fuel source even at low exercise 
intensities (Astorino & Harness, 2009). Encouraging athletes with an SCI to follow the CHO 
guidelines developed for able-bodied athletes may thus not be appropriate.  
To date only three research studies have been published evaluating the impact of CHO 
ingestion prior to and during exercise on fuel utilisation and performance with wheelchair 
athletes (Spendiff & Campbell, 2003, 2004, 2005). The studies were conducted with male 
athletes with an SCI who compete in wheelchair basketball and track events. All three 
research studies used the same exercise protocol: 1 hour at 65% VO2max followed by a 5-
minute rest and then a 20-minute performance test. However, only Spendiff and Campbell 
(2004) focused on CHO ingestion during the actual exercise bout. They compared the effect 
of two different drinking schedules; one treatment was 4 doses of 162 ml of a 7.6% CHO 
beverage, providing 49.25 g of CHO, ingested at the start, at 20, 40 and 60 minutes. The other 
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treatment was 2 dosages of 324 ml of the 7.6% CHO beverage, providing 49.25 g CHO, 
ingested at the start and after 60 minutes (Spendiff & Campbell, 2004). Their research design 
did not include a placebo control trial. When the participants consumed the 7.6% CHO 
treatment beverage in 4 doses they covered a greater distance during the performance test; 
however the difference was not statistically significant. The more frequent feeding regime 
resulted in higher blood glucose values at the end of the exercise trial. Limitations identified 
from Spendiff and Campbell (2004) included small sample size, lack of a placebo control trial, 
lack of dietary and physical activity control between the trials, and the overall length of the 
performance trial may have been too short. They indicated that perhaps a longer performance 
trial would place greater reliance on exogenous fuel sources (Spendiff & Campbell, 2004). 
 
Research Objectives and Hypothesis 
The primary objective of this research study was to assess the impact of the independent 
variable, CHO beverage consumed, on the total distance covered, average speed and maximal 
speed during a 30-minute performance trial. In addition we assessed the impact of the CHO 
beverage on dependent variables; RER, HR, blood lactate, blood glucose, and rating of 
perceived exertion (RPE) between the exercise and performance trials. It was hypothesized 
that ingesting the 8% CHO beverage during a moderate intensity exercise trial would maintain 
blood glucose levels, increase CHO oxidation and improve the performance measures in 
wheelchair athletes in comparison to a non-caloric placebo control. The secondary research 
objective was to analyze the dietary intake of the eight participants and to determine if they 
were within the recommended range of sport nutrition guidelines for able-bodied athletes and 
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active adults for macronutrient and fluid intake according to the ADA, ACSM, and DC 
(2000). 
 
1.2 LITERATURE REVIEW 
 
 
 To understand the impact of this research study, it is critical to appreciate what research has 
been completed with able-bodied athletes in the area of CHO utilization before and during exercise. It 
is also necessary to identify what has not been conducted with the specific population of interest, 
wheelchair athletes. During moderate to high intensity exercise, muscle tissue requires a fuel source, 
primarily CHO (Manore & Thompson, 2000). The CHO supply can come from endogenous sources 
(gluconeogenesis or glycogenesis) or exogenous sources (foods and fluids). The amount required by 
the body depends on the intensity of exercise, mode of exercise, fitness level of the participant, 
duration of exercise, dietary practices of the participant, pre-exercise feeding, and environmental 
conditions (Manore & Thompson, 2000). Extensive research has been carried out with able-bodied 
athletes studying CHO and performance during various types of exercise trials (varying durations, 
intensities, continuous, intermittent) and using different feeding regimes (Coyle et al., 1983; Murray, 
Seifert, Eddy, Paul, & Halaby, 1989; Below, Mora-Rodriguez, Gonzalez-Alonso, & Coyle, 1995; 
McConell, Kloot, & Hargreaves, 1996). However, research in this area with wheelchair athletes is 
limited to three studies, two of which have focused on CHO ingestion before exercise and only one 
that specifically studied the impact of CHO ingestion during exercise.   
Due to the level of injury, athletes with SCI have different quantities of active muscle tissue and 
fat mass. When matched for age and height, males with SCI had 16% less total lean tissue mass 
versus healthy controls and carried 47% more total fat mass (Jones, Goulding, & Gerrard, 1998). 
Such a difference in body composition would presumably result in different fuel recommendations 
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during rest and in particular during exercise when active lean tissue mass would be a critical variable. 
The following review of literature will focus on the previous research conducted in the area of CHO 
intake before and during exercise with able-bodied athletes. It will also review the limited research 
conducted with athletes with an SCI, discussing what is currently known regarding the impact of a 
SCI on fuel metabolism during exercise and the impact of the SCI on body composition. Three 
studies that have researched CHO intake before and during exercise with athletes with SCI will also 
be reviewed, highlighting key findings and research limitations. The ADA, ACSM and DC joint 
position paper on nutrition and athletic performance will also be presented. Currently no specific 
recommendations are in place for wheelchair athletes. Therefore the macronutrient and fluid 
recommendations for able-bodied athletes and active adults will be reviewed. 
 
1.2.1 Current Recommendations for Carbohydrate Intake Before and During Exercise 
In 2003 the International Olympic Committee (IOC) Nutrition Working Group developed 
nutrition guidelines for high performance able-bodied athletes. Based on the current research 
available, pre-exercise CHO should be consumed based on an athlete’s bodyweight and training 
intensity. Pre-exercise CHO should be consumed in quantities of 1 to 4 g·kg-1 body weight (Burke, 
Coyle, & Maughan, 2004). In 1996 the ACSM position statement on exercise and fluid replacement 
stated that during exercise lasting longer than 1 hour, it is recommended that CHO be ingested at a 
rate of 30 to 60 g·h-1 (0.7 g CHO·kg-1·h) to maintain oxidation of CHO and to delay the onset of 
fatigue (Convertino et al., 1996). The IOC guidelines for consumption during exercise are between 20 
to 60 g·h -1 of a CHO source that is readily available to maintain blood glucose. The 
recommendations for CHO intake during exercise are not based solely on body weight. The CHO 
dosage is also dependent on athlete tolerance. Ingestion of CHO at concentrations between 4 to 8% 
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provides enough glucose for maximal uptake and maintains glucose oxidation rates during exercise 
(Coyle & Montain, 1992). The form of CHO ingested during exercise does not seem to impact the 
ergogenic effect on exercise performance. Liquid or solid sources have been shown to improve 
performance to similar degrees (Jeukendrup, 2004).  
 
1.2.2 Pre-Exercise Carbohydrate Ingestion Research 
 The goals of pre-exercise fuel consumption are to continue to restore liver glycogen stores, 
especially following an overnight fast, ensure adequate hydration, prevent hunger, avoid 
gastrointestinal distress, and include foods that the individual feels confident with (Burke & Deakin, 
2000). 
 Early research conducted on CHO focused on avoiding any CHO ingestion before exercise. 
Coyle et al. (1983) had the participants arrive in a fasted state because it was believed that CHO 
consumption in the 30 minutes before exercise was detrimental to performance. It had previously 
been shown that pre-exercise CHO feeding resulted in hyperinsulinemia and an increased usage of 
muscle glycogen and blood glucose resulting in premature fatigue (Coyle et al., 1983). The feeding 
regime utilized by Coyle et al. involved a 12-h fast before the start of the exercise trial and the 
participants were fed either a placebo or glucose polymer after 20 minutes of exercise. The glucose 
feeding resulted in elevated blood glucose levels during the exercise trial and fatigue was postponed 
in 7 of the 10 participants. The concern with this recommendation of avoiding CHO pre-exercise was 
that most endurance athletes would not start a competitive event in a fasted state. The 
recommendation was thus not thought to be applicable to real life competitions. Therefore subsequent 
research with able-bodied athletes has studied the effect of specific pre-exercise feeding regimens in 
addition to varying feeding regimes during exercise.  
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 Results on the effect of pre-exercise CHO feeding on subsequent endurance performance are 
conflicting. Some have shown that pre-exercise CHO feeding increases endurance performance (el-
Sayer, Balmer, & Rattu, 1997) while other studies have shown no effect on performance (Febbraio, 
Chui, Angus, Arkinstall, & Hawley, 2000). One of the effects with pre-exercise CHO feeding is a 
change in fuel oxidation, shifting from FFA oxidation to an increase in glucose oxidation (Burke, 
Claassen, Hawley, & Noakes, 1998). Febbraio et al. (2000) determined the effect of CHO ingestion 
before, during, or in combination on exercise metabolism and performance. Seven endurance trained 
men participated in four separate exercise trials. The trials consisted of 120 minutes of steady state 
(SS) cycling at approximately 70% VO2peak followed immediately by a performance time trial cycle 
in which the participants were asked to complete a set amount of work as fast as possible (Febbraio et 
al., 2000). The participants had 1-minute rest between the SS exercise and the performance trial. The 
trials were performed under double blind conditions and in random order. The participants received 
either no CHO before or during, placebo 30-minute before and 2 g·kg-1 body weight CHO in a 6.4% 
CHO beverage during the SS exercise, 2 g·kg-1 body weight CHO in a 25.7% CHO beverage 30 
minutes before the exercise trial and placebo during the steady state, or 2 g·kg-1 body weight in a 
25.7% CHO beverage 30 minutes before and 2 g·kg-1 body weight in a 6.4% CHO beverage during 
the steady state trial.  The beverages that were consumed during the SS trial were provided at the 
onset of exercise and at 15-minute intervals.  
During the performance trial the participants did not consume a CHO source but they had access 
to water when needed. All four SS trials were conducted at the same intensity. The mean VO2, 
respiratory exchange ratio (RER), heart rate (HR), and rate of perceived exertion (RPE) were not 
significantly different between the exercise trials. Both CHO before exercise and placebo during and 
CHO before and CHO beverage during exercise had higher blood glucose values after the ingestion 
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of the pre-exercise CHO beverage but after 90 minutes of the SS exercise there was no difference in 
blood glucose levels between any of the four trials. Plasma insulin levels were significantly higher 
after the pre-exercise CHO intake in the CHO before and CHO beverage during exercise and CHO 
before plus placebo during exercise trials but there was no difference in values at the onset of the SS 
exercise trial. The normal hormonal response to exercise is for insulin concentration to be maintained 
at low levels so that glucose can be utilized as a fuel source and not stored. During the final 30 
minutes of the SS exercise plasma glucose concentration was higher in the both groups that were 
provided with CHO during exercise compared to the trials with the placebo beverage consumed 
during exercise (p<0.05). Fat oxidation was impacted by the amount of CHO that was ingested during 
the SS exercise. During the final 60 minutes of the SS, FFA and glycerol concentrations were 
elevated in the placebo trial compared with the other three trials in which CHO was provided either 
before, during or both (p<0.05). In the placebo exercise trial FFA and glycerol levels became elevated 
due to glycogen depletion. The increased concentration of glycerol is an indirect measure of an 
increase in lipolysis within the fat cells. Glycerol enters the energy pathway through glycolysis and 
the free fatty acids enter the citric acid cycle through beta oxidation. Glycerol also provides the 
carbon skeletons for glucose synthesis (McArdle, Katch, & Katch, 2006). Both trials with CHO 
provided during the SS exercise resulted in an increase in time trial performance, perhaps because 
plasma glucose was elevated and better maintained during the final hour of the SS exercise.   
 The concern with pre-exercise CHO feeding is that it results in metabolic consequences that 
may harm exercise performance. Much of the debate regarding pre-exercise CHO intake has been 
focused on its effect on subsequent blood glucose and insulin response. Therefore the natural 
progression in research would be to examine the effect of glycemic index (GI) of the pre-exercise 
foods and performance. Glycemic index is a rating of the impact of a CHO load on the blood glucose 
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response. The index is calculated by measuring the area under the blood glucose curve following the 
ingestion of 50g CHO of the test food (Siu & Wong, 2004). This value is then compared to the 
response by 50g CHO of reference food (Siu & Wong, 2004). It is also the rate at which the ingested 
CHO is made available to intestinal enzymes for hydrolysis and absorption (Coyle, 1991). Foods with 
a high GI result in a rapid increase in blood glucose levels, and foods with a low GI precipitate a 
much slower rise in blood glucose. Research has shown that ingestion of low GI foods prior to 
prolonged exercise may promote the availability of sustained CHO (Siu & Wong, 2004).  
Burke et al. (1998) studied the effects of the glycemic index of the pre-exercise meal on 
metabolism and performance when CHO was ingested according to current guidelines during the 
exercise trial. Six male cyclists performed 3 exercise trials that consisted of 2 hours of cycling at 70% 
VO2max followed immediately by a performance trial. The participants were blinded to the treatment. 
Two hours prior to each exercise the participants were provided with a high glycemic meal (HG), a 
low glycemic meal (LG), or a control meal with minimal CHO content (1 g CHO, 7 g protein). The 
CHO content of the glycemic meals were developed to provide 2 g·kg-1 body weight. The total 
caloric contents of the two glycemic index meals were not significantly different. The fluid content of 
the meal was also controlled, with each meal containing 1,100 ml of fluids. The HG meal had a 
glycemic index of 87 and the LG meal had a glycemic index of 37. 
 Thirty minutes after the ingestion of the HG or LG meal blood glucose concentration was 
significantly greater (7.9 ± 0.6 and 6.6 ± 0.5 mmol.l-1 respectively) than the blood glucose level 
following the control meal condition (4.4 ± 0.3 mmol.l-1) (Burke et al., 1998). Blood glucose levels 
returned to baseline at 60 minutes post meal intake in all three trials. The HG and LG meals 
consumed pre-exercise also resulted in a suppression of serum FFA concentration (<0.1 mmol.l-1) 
while the FFA levels in the control trial never dropped below the baseline values. Pre-exercise insulin 
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levels also differed significantly between the three meals. Serum insulin levels were 74.1 ± 10.1 
uU·ml-1 following the HG meal versus 43.9 ± 8.9 uU·ml-1 after the LG meal. The control meal 
resulted in fasting serum insulin values less than 10 uU·ml-1. 
 During the exercise trial the participants were provided with a 10% CHO beverage, immediately 
prior to, and at 20-minute intervals. When CHO was consumed during exercise at rates of 1 g·min-1, 
pre-exercise CHO intake had little effect on fuel utilization and endurance performance during a 2.5 h 
cycle. There was no significant difference in time to complete the performance trial for any of the 
treatment conditions. Although the participants were blinded to which meal they consumed they all 
indicated a preference for the LG meal pre-exercise (Burke et al., 1998). 
 Febbraio and Stewart (1996) investigated the effect of pre-exercise CHO consumption on 
muscle glycogen utilization and performance during a 2 hr ergometer cycle trial. This study involved 
three separate exercise and performance trials in which the six male participants were provided with 
the pre-exercise CHO meal 45 minutes prior to the exercise. The GI of the three meals was 
controlled.  A HG meal, LG meal or placebo control meal was provided pre-exercise during each of 
the three trials (Febbraio & Stewart, 1996). The participants were endurance trained individuals, 29 ± 
2 years of age and VO2peak of 62.1 ± 3.6 ml·kg·min-1. Since muscle glycogen content at the start of 
each exercise and performance trial needed to be consistent a 48 hr food and activity records were 
used to control for changes in dietary and activity patterns. The exercise trial consisted of 2 hours at 
70% VO2peak on a cycle ergometer, and no fuel source was provided during the trial. The participants 
did have access to 250 ml of water every 15 min. Oxygen uptake, HR and RER values were measured 
at 15-min intervals during the 2 hr cycle. Carbohydrate oxidation was then calculated from these 
values. The performance component started 1 min after the completion of the 2 hr cycle. The 
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participants were instructed to perform as much work (kJ) as possible in 15 minutes. Muscle biopsies 
were taken immediately before and after the exercise and performance trials.  
Respiratory exchange ratio and CHO oxidation values were lower during the placebo meal trial 
versus the HG and LG meal conditions (p<0.01). The HG meal resulted in higher blood glucose 
values but only for the sample collected at 15-min into the exercise trial (p<0.01). The HG meal also 
resulted in significantly lower plasma FFA concentrations compared to the LG meal condition and the 
placebo meal trial (p<0.05). Muscle glycogen concentration changed significantly from pre-exercise 
to post but there were no differences noted between the three meal conditions for the post-exercise 
muscle glycogen content. When assessing the impact of the GI meal on performance, Febbraio and 
Stewart (1996) stated that there were no performance differences between the three trials. Their main 
finding was that despite the varying GI of the CHO consumed pre-exercise there was no effect on the 
rate of muscle glycogen breakdown during exercise (Febbraio & Stewart, 1996). 
Education regarding pre-exercise CHO intake should focus on the timing, type, amount, and 
overall acceptance of the food choices. The point should be stressed that current research does not 
support the idea that pre-exercise CHO intake decreases endurance performance even when a drop in 
blood glucose and an increase in FFA utilization occurs at the start of the exercise trial. 
 
1.2.3 Research on Carbohydrate intake During Exercise 
 More recent research on the impact of CHO on sport performance has focused on the variety of 
sports and duration of exercise that may benefit from CHO supplementation during exercise. The goal 
of CHO feeding during exercise is to provide a steady flow of exogenous glucose into the blood with 
minimal gastrointestinal distress (Coyle, 2004). Coyle and Coggan (1984) stated that CHO ingestion 
would only benefit exercise performance if the intensity and duration were enough to deplete the 
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muscle glycogen stores. This suggests that only endurance events lasting 2 to 3 hours in length would 
benefit. However, Below et al. (1995) demonstrated that CHO ingestion during a 50-minute exercise 
trial at intensities over 75% VO2max followed immediately by a performance test resulted in improved 
performance. Four exercise trials took place, one with 1330 ml of a 6% CHO beverage, 1330 ml 
water, 200 ml of a 40% CHO beverage, or 200 ml water. Both CHO trials were matched for total 
CHO content (79 ± 4 g). The performance test involved the completion of a predetermined amount of 
work (joules) in the fastest time (min). The 6% CHO feeding resulted in significantly higher blood 
glucose and faster finish time for the performance trial. There were no significant differences noted 
between the CHO beverages and placebo trial for plasma lactate, heart rate, RER, or oxygen 
consumption during the exercise trial. 
The concentration of CHO consumed during exercise is critical for absorption and utilization. 
The two primary factors that regulate glucose absorption appear to be concentration of the CHO 
source and the volume of fluids consumed (Coyle & Montain, 1992). Research with able-bodied 
athletes has identified an ideal range for CHO concentration of 4 to 8% during moderate to high 
intensity exercise (Coyle & Montain, 1992). Ingestion of CHO beverages at this concentration 
provides enough glucose for maximal uptake and maintains oxidation rates during exercise (Coyle & 
Montain, 1992).  
Exercise represents a physiological stress placed on the body which then requires major 
cardiovascular and metabolic adjustments to maintain homeostasis (Meeusen, Watson, Hasegawa, 
Roelandst, & Piacentini, 2007). Exercise causes an increase in cortisol, glucagon and sympathetic 
nervous system hormones (epinephrine and norepinephrine) in order to increase fuel availability 
(Coyle, 1983). In order for the body to adjust to these changes, the central nervous system (CNS) 
needs to be provided with a sufficient glucose and oxygen supply (Meeusen et al., 2007). The 
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maintenance of blood glucose during exercise in order to meet the needs of the CNS is therefore a 
critical component in preventing the onset of fatigue. Nybo (2003) investigated how glucose 
supplementation during prolonged exercise would affect neuromuscular activation, looking at a 
sustained maximal voluntary muscle contraction measured by a strain gauge dynamometer 
immediately after a 3-hour cycle trial. The participants were provided with either a 6% glucose 
beverage to maintain blood glucose levels or a placebo drink leading to the development of 
hypoglycaemia. The total amount of CHO provided in the glucose trial was 200 ± 10 g and the total 
volume of fluid consumed during both trials was 3.3 ± 0.2 litres. The placebo beverage led to a 
significant increase in RPE (16 ± 1 vs. 13 ± 1 in the glucose trial) during the last hour of the cycle 
trial. The placebo trial, which led to the development of hypoglycaemia, was also associated with an 
impaired neuromuscular performance during the sustained contraction (Nybo, 2003). The initial onset 
of force was similar between the placebo and glucose trials but the hypoglycaemia that ensued with 
continued exercise impaired the ability to sustain high neural drive over time. Nybo suggested that 
“the mechanism underlying the hypoglycaemia-induced central fatigue could be a direct effect of 
reduced substrate delivery to the brain”. Carbohydrate supplementation during exercise was able to 
prevent the onset of hypoglycaemia and maintain activation drive from the CNS, delaying central and 
peripheral fatigue (Nybo, 2003). 
 
1.2.3.1 Carbohydrate Feeding Late in Exercise 
Another feeding strategy that has been researched with the able-bodied athlete population is the 
ingestion of CHO late in exercise once muscle glycogen and blood glucose levels are starting to 
diminish (McConell, Kloot, & Hargreaves, 1996). The researchers’ aim was to see if CHO consumed 
late in exercise would be of greater benefit to exercise performance versus intermittent CHO feeding 
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from the start of the trial. The total amount of CHO consumed during the 2-hour cycle was the same 
in the 7% CHO trial and the 21% CHO trial. The total dosage was 157.5 g CHO. It was hypothesized 
that ingestion of a large amount of CHO late in exercise would improve 15-minute performance to the 
same extent or greater than CHO ingestion throughout the exercise trial (McConell et al., 1996). The 
exercise trial was a 2-hour bicycle ride at 70% VO2peak followed immediately by a 15-minute 
performance ride. The results did not support their research hypothesis. When the 7% CHO beverage 
was consumed every 15 minutes during the 2-hour exercise trial the participant’s ability in the 
performance ride was significantly increased as indicated by increased work output in comparison to 
the placebo trial (p<0.05). Providing the 7% CHO beverage during the 2-hour cycle improved the 
performance of seven of the eight participants compared to feeding 21% CHO late in exercise. It was 
concluded that the negative impact of not consuming CHO for the first 90 minutes of the exercise 
trial carried over to the performance in the 15 minute trial. 
 
1.2.4 Composition of Carbohydrate Consumed During Exercise 
Carbohydrate consumption during exercise has been shown to be limited due to the rate of 
absorption. Jeukendrup (2004) concluded that absorption of a single CHO source during exercise 
would plateau at approximately 1.0 g·min-1. The cause of this plateau is thought to be the limitation 
of the transportation of glucose across the cell membrane. Saturation of glucose transport proteins, 
GLUT-2 and sodium dependent glucose transporter-1 (SGLT-1) may occur, limiting the CHO 
oxidation rate during exercise. In an effort to address this issue, several studies have focused on the 
impact of consuming multiple simple CHO sources to see if oxidation could be increased, thereby 
increasing endurance performance. Providing a combination of CHO sources increases exogenous 
CHO oxidation rates during exercise because glucose and fructose are absorbed by different intestinal 
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transport mechanisms. Glucose uses SGLT1 and fructose uses GLUT-5 transporters. With different 
mechanisms of transport there would likely be less competition for absorption leading to enhanced 
transport of both substrates (Jeukendrup, 2004). 
 Jentjens & Jeukendrup (2005) investigated whether a mixture of glucose (GLUC) and fructose 
(FRUC) when ingested at a high rate (2.4 g·min-1) would lead to even higher exogenous CHO 
oxidation rates (>1.3 g·min-1). The participants were eight trained male endurance athletes, with a 
mean age of 26 years, and a mean VO2max of 68 ml·kg-1·min-1. Each participant performed three 
exercise trials which consisted of 150 minutes at 50% maximal power output (Wmax) while ingesting 
either a 9.23% GLUC beverage, an 18.46% GLUC and  FRUC beverage (9.23% of each), or  water. 
The treatment beverages were provided in a 600 ml bolus during the first 3 minutes and 150 ml bolus 
at 15 minutes intervals during the exercise trial. The average amount of glucose consumed during the 
GLUC trial was 1.2 g·min-1 and for the GLUC and FRUC trial the average dosage was 2.4 g·min-1.  
The rate of CHO oxidation was significantly higher in the GLUC trial versus the control trial. 
During the 60th to 150th minute of the exercise trial CHO oxidation was significantly higher in the 
GLUC and FRUC trial compared to the GLUC trial. Fat oxidation was significantly lower during the 
two CHO trials; fat represented 61% of the total energy in the water trial and only 34% in the GLUC 
and FRUC trial. The rate of endogenous CHO oxidation was significantly lower in the two CHO 
trials compared with the water trial: 1.6 g·min-1 during the water trial and 1.1 g·min-1 during the 
GLUC and FRUC trial. No difference was found between the two CHO trials regarding endogenous 
CHO oxidation. Maximal glucose oxidation rates were reached when glucose was ingested at 1.2 
g·min-1. Findings from this study support the sparing effect of CHO ingestion during exercise on the 
muscle and liver glycogen stores. Combined ingestion of large amounts of glucose and fructose 
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during 150 minutes of cycling exercise resulted in approximately 50% higher CHO oxidation rates 
compared with glucose alone. Peak CHO oxidation values for glucose plus fructose was 1.75 g·min-1. 
 In order to achieve high CHO oxidation rates during exercise, endurance athletes should be 
advised to consume a mixture of CHO sources at dosages that provide 1.2 g·min-1 of each source 
(Jentjens & Jeukendrup, 2005). Since the total amount of fuel consumed would be quite large, this 
recommendation would only benefit performance if an athlete could physically tolerate the fuel load. 
This study claims to have demonstrated that during the GLUC and FRUC trial, the oxidation rate of 
1.75 g·min-1 could have been the highest oxidation rate that is physiologically possible when multiple 
transportable CHO sources are ingested orally (Jentjens & Jeukendrup, 2005).  
 It is of note that consuming large amounts of only fructose during endurance exercise is not 
recommended because it has a slower absorption rate compared to glucose or sucrose. Therefore it 
has the potential to lead to gastrointestinal upset (Jentjens & Jeukendrup, 2005). Jentjens & 
Jeukendrup did not find any differences in gastrointestinal discomfort between all three trials. The 
most common complaints were an urge to urinate and a feeling of being bloated. 
 In a subsequent study Jentjens et al. (2006) studied whether a glucose and fructose beverage 
would result in greater CHO oxidation and higher fluid availability during exercise in the heat versus 
an isocaloric glucose beverage. A previous study had shown that a combination of CHO sources 
(glucose and fructose) resulted in high exogenous oxidation rates (Jentjens & Jeukendrup, 2005), but 
the same response was not shown with exercise trials conducted in the heat. The exercise trial was 
120 minutes at 50% maximal power output at an ambient temperature of 32 degrees Celsius. The 
study was comprised of 3 trials. Three treatment beverages were provided in random order with 1.5 g 
glucose·min-1, 1.0 g glucose plus 0.5 g·min-1 fructose, or plain water (Jentjens et al., 2006).  Dosages 
for the three treatment beverages were a bolus amount of 600 ml consumed during the first three 
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minutes of the exercise trial and 200 ml every 15 minutes, resulting in a total beverage intake of 
approximately 2 litres. The total CHO intake was 180 g of either glucose only or 120 g of glucose and 
60 g of fructose. The CHO concentration of the beverages was 9%.  
 Exogenous CHO oxidation rates during the last hour of exercise were 36% higher in the glucose 
plus fructose group compared to the glucose only trial (p<0.05). Peak oxidation rates during the 
exercise trials were 1.1 g·min-1 for the glucose plus fructose trial and 0.8 g·min-1 for the glucose trial 
(Jentjens et al., 2006). Endogenous CHO oxidation was significantly lower (p<0.05) in the glucose 
plus fructose trial compared to the water trial. During the last part of the exercise trial (90 to 120 min) 
the rate was 1.0 g·min-1 for glucose plus fructose trial versus 1.5 g·min-1 for the water trial. Muscle 
glycogen oxidation was not significantly different between the glucose and the water trial. The two 
CHO trials significantly reduced fat oxidation rates compared to the water trial.  Fat oxidation 
represented 61 ± 4, 48 ± 3 and 45 ± 1 % of total energy expenditure in the water, glucose, and glucose 
plus fructose trials respectively. Ingestion of glucose and fructose in combination resulted in high 
CHO oxidation rates (>1.0 g·min-1) and reduced endogenous CHO oxidation by approximately 26% 
compared with the water trial. Since exercising in the heat has been shown to increase muscle 
glycogen utilization (Jentjens et al., 2006), using a combination of CHO sources during exercise may 
delay the onset of fatigue by sparing endogenous CHO sources. 
 
1.2.5 Impact of Gender on Fuel use During Exercise 
Most studies that have assessed fuel utilization during exercise with the athletic population have 
used a sample of only male athletes (Brisswalter et al., 2000; Katsumi & Kando, 1998; Dumke et al., 
2007; Below et al., 1995). Women have lower RER values during exercise in comparison to men, 
indicating a greater reliance on fat oxidation (Devries, Hamadeh, Phillips, & Tarnopolsky, 2006; 
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Braun, Gerson, Hagobian, Grow, & Chipkin, 2005). The reduced oxidation of CHO during exercise 
could be due to a decreased utilization of muscle glycogen, lower utilization of blood glucose, or both 
(Horton, Grunwald, Lavely, & Donahoo, 2006). The variation in estrogen concentration between 
genders play an important role in these noted differences (Devries et al., 2006). The current study 
included female wheelchair athletes, therefore menstrual cycle hormonal fluctuations will be 
discussed. McLay, Thomson, Williams and Rehrer (2007) stated that it is important to control for 
menstrual cycle phase in all exercise metabolism studies involving female participants, due to the 
potential influence that fluctuations in endogenous sex hormones have on muscle glycogen 
concentration. Hackney (1999) found that muscle glycogen utilization was lower during the luteal 
phase when oestrogen was the highest and that a significant negative relationship existed between 
oestrogen level and glycogen utilization. Respiratory exchange ratio was significantly lower in the 
luteal phase versus the follicular phase, suggesting enhanced lipid utilization during exercise 
(Hackney, 1999).  Bailey, Zacher and Mittleman (2000) studied the impact of a CHO beverage 
consumed during exercise to see if providing a fuel source during exercise would negate the impact of 
the menstrual cycle on fuel utilization. Their research design involved four exercise trials, two during 
the luteal phase and two during the follicular phase. During both phases the nine female participants 
were provided with either a 6 % CHO beverage or placebo. The beverages were provided every 30 
minutes and the participants were told to cycle to exhaustion. Their results indicated that the time to 
exhaustion was increased with the CHO beverage but there was no difference between the luteal and 
follicular phase. There was also no difference between phases for FFA, plasma glucose or insulin 
levels.  
 
 
18 
 
1.2.6 Impact of Carbohydrate Ingestion on Rating of Perceived Exertion 
 Most research focuses on the impact of feeding on quantitative measures such as blood glucose, 
plasma insulin, lactate, etc., because they provide values that are easier to compare across different 
study designs. It is equally important however to also understand the qualitative impact of these 
changes. The qualitative questions are more challenging to interpret, but their importance may 
provide additional insight into the performance benefit of CHO feeding. 
 Backhouse, Bishop, Biddle, & Williams (2005) examined the influence of regular CHO 
beverage consumption on affect (pleasure-displeasure) and rating of perceived exertion (RPE) during 
a 2 hour cycle at approximately 70% VO2max. The research protocol involved nine endurance male 
athletes, the design was randomized and under double-blinded conditions. The exercise trials 
provided the athletes with either a placebo immediately before the exercise trial and at 15-minute 
intervals during exercise or a 6.4% CHO beverage (5 ml·kg-1 bodyweight) before and 2 ml·kg-1 
bodyweight at 15-minute intervals during exercise. The methodology that was used involved the 
feeling scale (FS) to measure the affective dimension of pleasure to displeasure (Backhouse et al., 
2005). It is an eleven point scale from –5 meaning very bad to +5 meaning very good. The FS was 
administered pre-exercise, at 15-minute intervals, and in the post exercise phase. The RPE scale was 
administered every 15 minutes during the exercise trial to monitor the perceived exertion of the 
participants. Heart rate was also monitored. Dietary intake was recorded for 2 days prior to each 
exercise trial and there were no significant differences between energy intake and composition 
between the trials. Heart rate and percent VO2max did not differ between trials indicating that exercise 
intensity measured using quantitative scales were similar in both trials. Plasma glucose was 
significantly higher immediately post exercise in the CHO trial compared with the placebo trial, with 
values of 6.1 ± 0.3 mmol.l-1 and 5.4 ± 0.3 mmol.l-1, respectively. The overall pleasure ratings were 
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higher during the CHO trial and recovery period compared with the placebo trial. For the placebo trial 
the FS indicated that the pleasure ratings were becoming less positive as the exercise trial continued. 
At 75 minutes the RPE was significantly lower in the CHO trial compared with the placebo trial 
(p<0.05).  
Utter et al. (2007) studied the impact of CHO feeding during intermittent exercise on RPE with 
12 male cyclists. The exercise trial included 2 hours at 73% VO2peak with 3-minute rest intervals every 
10 minutes. The participants were provided with a 6% CHO beverage or a placebo beverage 15 to 30 
minutes pre-exercise and at 15-minute intervals during the trial. During the last minute of each 10-
minute bout of exercise the participants rated their overall body RPE. The RPE patterns were 
significantly lower during the CHO versus placebo trials. A critical limitation to this study was the 
pre-exercise feeding protocol. The participants were instructed to arrive at the testing site following a 
5 hour fast. During the placebo trial the participants would then not receive any form of energy for 
another 2 hours.  
 
1.2.7 Current Dietary Guidelines for Able-Bodied Athletes  
The current recommendations for able-bodied athletes and active adults are from a joint position 
paper Nutrition and Athletic Performance (ADA, ACSM, DC, 2000, 2009). The joint position paper 
was developed by the ADA, ACSM and DC. Currently there are no specific dietary recommendations 
for wheelchair athletes. Therefore, able-bodied guidelines will be used for comparison. The position 
paper is focused on recommendations for adult athletes and does not focus on a specific type of sport 
or competitive event.  
 The first priority for all athletes is to achieve an energy balance. Energy balance is vital for 
maintaining muscle tissue, proper immune function, reproductive function for female athletes, and 
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optimal sport performance (ACSM, ADA, DC, 2000). The energy requirements of the human body 
are divided into three components; resting energy expenditure (REE), the thermic effect of food 
(TEF) and the energy expended with daily life and physical activity. Collectively, the components 
determine each individual’s total daily energy requirements.  Active adults are advised to consume an 
energy intake of 1.5 to 1.7 times their REE or to consume between 37 to 41 kcal·kg-1·d (National 
Research Council (NRC), 1989).  Numerous equations exist for calculating REE for adults. Currently 
there are not any specific equations for wheelchair athletes. Note that the World Health Organization 
(WHO) energy equations for resting energy expenditure are designed for able-bodied individuals, and 
thus, they may not be suitable for individuals with a chronic disease or   disability (Abel, Platen, 
Rojas Vegas, Schneider, & Struder, 2008).  
Abel et al. (2003) measured resting energy requirements for 27 athletes with varying levels of 
physical ability (SCI, spina bifida, amputations, post-polio syndrome). They found basal metabolic 
rate to be 65.4 ± 14.1 kcal·h-1 for the hand bike athletes and 60.3 ± 9.1 kcal·h-1 for the wheelchair 
racing athletes. These values would result in resting daily requirements of 1,488 to 1,560 kcal·d-1 plus 
additional energy needs for physical activity. Taking their findings and applying them to all groups of 
wheelchair athletes would not be appropriate. Since there are no specific energy recommendation for 
wheelchair athletes able-bodied guidelines for active adults, 37 to 41 kcal·kg-1·d-1, will be used for 
comparison in this study. This limitation in available evidence suggests that we can only assume that 
the current dietary recommendations for able-bodied athletes can be applied to wheelchair athletes 
(Broad, 2006, p. 747). 
Daily CHO intake is crucial for optimal sport performance. In previous sections, we have 
discussed in detail the optimal timing and type of CHO intake before and during exercise. The 
recommendation for total CHO is 6 to 10 g·kg-1body weight·d-1 (ACSM, ADA, DC, 2000). The CHO 
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recommendation represents the CHO dosage necessary to maintain blood glucose levels and restore 
muscle glycogen levels on a daily basis. Carbohydrate intake is crucial for athletes training in 
endurance and strength events (Burke, Kiens, & Ivy, 2004). The availability of CHO as a fuel source 
for exercising muscles and the central nervous system becomes a limiting factor in sport performance 
(Burke et al., 2004). Daily CHO intake can therefore limit performance in both endurance events over 
90 minutes and intermittent high-intensity exercises (Burke et al., 2004). The current CHO guidelines 
are based on research which found that the threshold for glycogen storage was achieved with an 
intake of 7 to 10 g·kg-1 body weight·d-1 (Costill et al., 1981). 
Daily protein recommendations for able-bodied athletes are higher than the current 
recommended dietary allowance (RDA) of 0.8 g·kg-1·d-1. Recommended dietary allowances are 
defined as “the average daily dietary nutrient intake level sufficient to meet the nutrient requirements 
of nearly all (97 to 98%) healthy individuals in a particular life stage and gender group” (Institute of 
Medicine (IOM), 2004). The ACSM, ADA, DC (2000) protein recommendation for strength-trained 
athletes is to consume between 1.6 to 1.7 g·kg-1 body weight·d-1. The recommendation for endurance 
trained athletes is 1.2 to 1.4 g·kg-1 body weight·d-1. These recommendations for additional protein 
intake above the RDA are to account for a small percentage of protein being used as a fuel source 
during exercise and to allow for complete muscle recovery post-exercise (Lemon, 1998). Fat intake is 
an important component to an athlete’s diet; however, there is no performance advantage to 
consuming a very fat restricted diet (ACSM, ADA, DC, 2000). The current recommendation is based 
on a percentage of total energy intake. Fat should provide between 20 to 25% of total caloric intake. 
Including healthy sources of fat on a daily basis will ensure that athletes meet their requirements for 
fat soluble vitamins (A, D, E and K) and essential fatty acids. 
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The recommendations for total fluid intake are gender specific. The adequate intake (AI) for 
females is 2,700 ml and for males is 3,700 ml. An AI value is “the recommended average daily intake 
level based on observed or experimentally determined approximations or estimates of nutrient intake 
by a group of apparently healthy people that are assumed to be adequate when and RDA cannot be 
determined” (IOM, 2004). The AI for fluids includes total water (beverages, drinking water, and 
foods). Approximately 80% of total water intake comes from fluids but 20% is accounted for by foods 
consumed (IOM, 2004). 
 
1.2.7.1 Dietary Assessment Tools 
Dietary assessment can be conducted in numerous ways (e.g. 24 hour food recall, food 
frequency questionnaire, weighed food record), each method having strengths and weaknesses. For 
the 24 hour food recall and the food frequency questionnaire, both are completed by memory 
therefore the assessment tool not have impacted intake. Since the accuracy of the tools is depended on 
memory, errors may occur (Block & Hartman, 1989). The chosen method for the current study was a 
3-day food record. The primary purpose of the 3-day food record was to control for dietary intake 
leading into both exercise and performance trials. The secondary purpose of the 3-day food record 
was to assess the participant’s dietary intake. One of the main advantages with this method is that it is 
not reported by recall (Hyman et al., 1982). The researcher can also gain detailed information on food 
intake patterns, food preparation and quality of choices (Hammonds, 2000).  Some of the 
disadvantages with 3-day food records are: issues with underreporting, that it requires participants to 
measure accurately and judge portion sizes, and the impact of the measurement effect (Hammonds, 
2000). Underreporting is widespread among athletes and its magnitude should be addressed when 
interpreting the results (Magkos & Yannakoulia, 2003). Food records have been compared against the 
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gold standard for energy expenditure in human participants, doubly labelled water (DLW). Edwards, 
Linderman, Mikesky, and Stager (1993) found that for endurance female athletes the percent of 
energy underreported from a 7-day food record compared to DLW was -29.8 ± 17.9%. Ebine, 
Rafamantanantsoa, and Nayuki (2002) revealed that underreporting was also a concern with male 
athletes. The percent of energy recorded in the 7-day food record compared to DLW was -12.4 ± 
9.1%. A weighed 7-day food record would be a more accurate measure but it is not portable and 
athletes frequently eat away from home due to their training schedule. Another possible limitation of 
the food record is the measurement effect. The measurement effect is the tendency for participants to 
change their eating habits while keeping the food records (Hyman et al., 1982). As a method to 
control for dietary intake between the exercise and performance trials, a 3-day food record will 
enhance the internal validity of the research study. It also ensures greater dietary control then the 
previous research conducted in this area with wheelchair athletes (Spendiff and Campbell, 2005, 
2004, 2003).  
 
1.2.8 Current Research with Wheelchair Athletes 
 Wheelchair athletes with a SCI experience a loss of motor function, sensation and control of 
autonomic function at and below the level of injury (Spendiff & Campbell, 2004). They also 
experience unique changes to their cardiorespiratory, metabolic and thermoregulatory systems that 
reduce their overall physiological capacity (Bhambhani, 2002). Paraplegic athletes exhibit cardiac 
limitations at peak exercise contributing to lower VO2peak (Vinet et al., 1997). An explanation for the 
reduction in VO2 peak may be a reduction in active muscle tissue (Vinet et al., 1997). In addition, 
cardiac limitations, such as a lower stroke volume, are explained by a loss of central sympathetic 
vasomotor outflow and a loss of muscle pump action below the level of the injury (Vinet et al., 1997). 
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A decrease in muscle blood flow would have a direct impact on nutrient delivery to the active muscle 
tissue during exercise.  
When physiological responses are evaluated across a range of spinal cord injury levels in 
wheelchair athletes, important considerations need to be taken into account. Heart rate, blood lactate 
levels, VO2max, and cardiac output are inversely related to the level of lesion (Bhambhani, 2002). 
Training may negate some of these physiological differences. Campbell, Williams and Lakomy 
(2004) reported that endurance-trained athletes with SCI were able to maintain velocities equivalent 
to the same relative exercise intensity (75% VO2peak) for prolonged periods regardless of injury level.  
The target population for this research project was trained wheelchair athletes with different spinal 
cord injury levels and physical impairments. 
 Campbell et al. (2004) examined the physiological and metabolic responses of athletes with SCI 
in different racing classes, dependent on level of injury, for 90 minutes at 75% VO2peak. Twenty 
athletes with a variety of SCI levels participated in the research study. The athletes were grouped by 
injury level according to the Paralympic Racing Classification system (Campbell et al., 2004). Eight 
athletes were in the T3 racing category, indicating athletes with paraplegia with a lesion level 
between thoracic (T) T1 to T7. Nine athletes were in the T4 racing class (paraplegia with lesion levels 
below T7). Their results indicated that few differences were found between the physiological and 
metabolic response of the two racing classes. However differences were found with respect to heart 
rate response during the exercise regime. During the 90-minute test a gradual increase in heart rate 
similar to that experienced by able-bodied athletes was only apparent in the T4 athletes. The athletes 
in the T3 class experienced a heart rate plateau after an initial increase at the onset of the exercise 
regime.  The T3 athletes have less recruitable muscle mass; therefore, stroke volume and heart rate 
may remain stable because there would be less competition between the muscle tissue and skin for the 
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blood volume as the athlete’s body temperature increases (Campbell et al., 2004). Due to the higher 
level of SCI in the T3 group, HR may have been limited due to disruptions to the sympathetic 
nervous system (Bhambhani, 2002).  
For both groups of athletes the RER values decreased significantly as the exercise test 
progressed (p<0.05).  Respiratory exchange ratio values of 0.91 for the T3 athletes and 0.92 for the 
T4 athletes at the start of the exercise dropped to 0.82 for the T3 athletes and 0.80 for the T4 athletes 
at the completion of the 90-minute exercise. The decrease in RER as the exercise regime progressed 
indicates a switch to lipid metabolism. The results of this study also indicated that protein metabolism 
contributed to the total energy expenditure of the exercise regime. By the end of the 90-minute test, 
plasma ammonia and urea concentrations had significantly increased from resting values for the 
paraplegic athletes (p<0.05). These results are consistent with exercise testing in the able-bodied 
population.  
 
1.2.9 Research Conducted on Fuel Utilization with Wheelchair Athletes  
One of the challenges in working with wheelchair athletes is that not much is known regarding 
their fuel requirements during exercise. Most of the research conducted in the area of rehabilitation, 
not high performance sport (Bhambhani, 2002). Limited research with this population has shown that 
the primary substrate utilized during submaximal wheelchair exercise is glycogen, as shown by 
depletion of glycogen in the deltoid muscle (Bhambhani, 2002). Knetchle, Muller, Willmann, Eser, 
and Knecht (2004) assessed the rate of fat oxidation at three different exercise intensities in trained 
athletes with SCI. The three exercise trials were 20 minutes in length at intensities of 55, 65 and 75% 
VO2peak, and the participants had 15 minutes of rest between each trial. Fat oxidation in wheelchair 
cycling, in contrast to cycling and running with able-bodied athletes, did not differ between the three 
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exercise intensities (Knetchle et al., 2004). The study did show that CHO oxidation increased from 
1.1 ± 0.4 g·min-1 at 55% VO2peak to 1.7 ± 0.5 g·min-1 at 75% VO2peak (p<0.05).  
Astorino and Harness (2009) also examined the impact of an SCI on substrate metabolism at 
rest and during exercise. Nine men and women with an SCI participated in the study which involved 
two 30-min submaximal exercise trials. RER values increased significantly from 0.85 ± 0.07 at rest to 
0.95 ± 0.01 during exercise (p<0.05). Carbohydrate oxidation increased during the exercise trials, 
peaking at 2.6 ± 0.3 g·min-1 (Astorino & Harness, 2009). Their findings further demonstrated that 
individuals with an SCI are dependent on CHO as the dominant fuel source during low to moderate 
intensity exercise. These results are important for all wheelchair athletes, especially those with a high 
levels of injury. Their ability to store adequate muscle glycogen for their competitive event or training 
session would be further compromised due to a reduction in active muscle tissue. These findings 
support the notion that additional exogenous CHO may be needed to maintain endurance training 
performance. Providing athletes with the top end of able-bodied athlete’s CHO recommendations 
during exercise may allow the athletes to train for longer time periods and enhance their endurance 
capacity.  
To date only three studies have been published examining the CHO needs during exercise of 
athletes with SCI (Spendiff & Campbell, 2003, 2004, 2005). Their studies were conducted with male 
athletes that compete in wheelchair basketball and track events. All three research studies used the 
same exercise protocol. One hour at 65% VO2max followed by a 20-minute performance test. Only 
Spendiff and Campbell (2004) focused on CHO intake during exercise. They compared the effect of 
two different drinking schedules. One treatment was 4 doses of 162 ml of a 7.6% CHO beverage, 
providing 49.25 g of CHO, ingested at the start and at 20, 40 and 60-minute marks. The other 
treatment was 2 dosages of 324 ml of the 7.6% CHO beverage, providing 49.25 g CHO, ingested at 
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the start and after 60 minutes. When the seven participants consumed the 7.6% CHO treatment 
beverage in 4 doses they covered a greater distance during the performance test; however the 
difference was not statistically significant. There was a significant difference between the feeding 
regimes with regard to blood glucose fluctuations; specifically the 4 x 162 ml protocol resulted in 
more steady blood glucose levels. The blood glucose values for the 4 x 162 ml feeding regime ranged 
from 3.6 ± 0.6 mmol·l-1 at rest up to 4.9 ± 1.0 mmol·l-1 at the 40-min mark. Respiratory exchange 
ratio of 0.91 ± 0.05 throughout the whole exercise and performance trial may suggest a steady rate of 
CHO oxidation during the 4 x 162 ml protocol. The RER values for the 2 x 324 ml protocol decreased 
over the course of the 60-minute trial, indicating a switch in fuel sources and increase utilization of 
fatty acids. The 2 x 324 ml feeding regime resulted in a greater increase in FFA concentrations during 
the exercise trial. This indicated that the CHO feeding was not enough to maintain the plasma glucose 
concentrations and RER values. 
  Providing a CHO at frequent intervals during exercise at moderate intensity suppresses 
endogenous glucose production in able-bodied athletes, allowing for a decrease in the rate of hepatic 
gluconeogenesis (Jeukendrup et al., 1999). Focusing on blood glucose is critical because if it can be 
maintained along with CHO oxidation, as shown with higher RER values, then this might improve 
exercise performance in sprint finish events (Spendiff & Campbell, 2004). This would have a direct 
impact on real world athletic performance.  
  Spendiff and Campbell (2003) focused on pre-exercise CHO feeding in athletes with SCI. Eight 
participants were provided with either a beverage containing 48 g of CHO or a placebo beverage 20 
minutes prior to the exercise protocol. The exercise protocol was conducted on an arm crank 
ergometer. Participants covered more distance in the 20-minute performance trial when the CHO 
source was consumed pre-exercise, 10.83 ± 0.74 km versus 10.20 ± 1.01 km with the placebo 
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beverage (p<0.05).  Building on these findings, Spendiff and Campbell (2005) investigated the 
performance impact of varying CHO concentration with eight athletes with a SCI. They chose two 
treatment beverages: 4% CHO or 11% CHO consumed in one dose 20 minutes before the exercise 
trial. The participants received either 24 g (4% CHO) or 72 g (11% CHO) of dextrose in a 600 ml 
solution, and no beverage was provided during the exercise trial or performance ride. The exercise 
and performance trial was conducted on a wheelchair roller system and consisted of 60 minutes at 
65% VO2peak followed by a 20-minute performance test.  
The lower CHO feeding regime resulted in a greater increase in FFA at the end of the 60-minute 
exercise trial (p<0.05). The results indicated no difference in distance covered or mean power output 
during the 20-minute performance ride between the two CHO beverages. There was no significant 
difference in the VO2, minute ventilation, RER, heart rate, blood lactate, and blood glucose 
concentrations between the high and low CHO trials. Spendiff and Campbell noted that due to the 
small sample size a significant difference was not found but there was a trend towards higher RER 
and blood glucose concentrations in the performance trial following the high CHO beverage 
compared to the low CHO dosage. The trend towards an increased rate of CHO oxidation, indicated 
by the elevated RER values, in the high CHO trial may have caused a slight shift in substrate 
utilization from FFA to glucose. The findings from this study suggest that low lesion paraplegic 
athletes who possess a smaller amount of active muscle mass respond in a similar way to pre-exercise 
CHO ingestion as able-bodied athletes (Spendiff & Campbell, 2005).   
Limitations identified from Spendiff and Campbell (2005) included small sample size, lack of 
dietary and physical activity control between the trials, and the duration of the exercise trial. Spendiff 
and Campbell also suggested that future research should increase the duration of the performance trial 
to increase the reliance on exogenous CHO sources.  
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Even though no performance difference was found, the benefit of a high CHO dosage may be 
important to investigate further since wheelchair athletes have a lower amount of active muscle 
tissue. Therefore their ability to store glycogen in preparation for competitive events may be 
compromised (Bhambhani, 2002). If muscle glycogen stores are minimal at the onset of exercise, 
exogenous CHO may become a more crucial energy source for prolonged events. Building upon the 
knowledge gained from these three research studies and minimizing many of the limitations noted 
(Spendiff & Campbell, 2003, 2004, & 2005); the current study implemented a frequent CHO feeding 
regime during a moderate intensity exercise trial in an attempt to improve performance during 
prolonged exercise.  
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CHAPTER 2 
2. METHODS 
 
2.1 Participants 
This research project included eight participants with varying levels of ability (SCI = 7, 
CP = 1) from national and developmental level wheelchair sports teams. All of the participants 
were competing in sporting events at a provincial or national level. All of the participants were 
training on a consistent basis. Informed consent was obtained from each participant. 
Individuals were excluded if they were being treated for any medical condition or injury that 
would impact their ability to complete the exercise and performance trials. Consent forms 
(Appendix I) and study procedures were approved by the University of Saskatchewan 
Biomedical Research Ethics Board (Appendix II) prior to data collection and testing. The 
participants were 6 males and 2 females, 24 to 45 years of age. Tables 1 and 2 provide 
descriptions of the participants, sport involvement and there sport specific classification. The 
research study used a cross-over design with the participants acting as their own controls. This 
design was chosen because wheelchair athletes have very unique characteristics dependent 
upon their level of SCI injury and/or nature of their physical disability. The participants that 
were included in this study had a wide variety of spinal cord injuries or physical disabilities. 
One of the primary goals of this research project was to maximize the internal validity of the 
study and to identify a relationship between the independent variable, CHO beverage, and the 
dependent variables of RER, HR, RPE, blood glucose, average speed and distance covered in 
the performance trial.  
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 Table 1 Participant Characteristics 
# 
code 
Gender Age (yr) Disability Body 
weight (kg) 
Height 
(cm) 
BMI 
1 Male 45 SCI, T4 79.2  165  29.1 
2 Male 28 CP 71.9  168  25.3 
3 Female 27 SCI, T1 52.8  151  23.1 
4 Male 24 SCI, L1 92.7  180  28.6 
5 Male 43 SCI, T3 84.1  189  23.6 
6 Male 44 SCI, C6 68.0 182  20.5 
7 Male 41 SCI, C 5-6 90.7  188  25.7 
8 Female 34 SCI, T12-L1 88.6  185  25.0 
Mean 
± SD 
 36 ± 8.5  78.5 ± 13.7 176  ± 13 25.1 ± 2.8 
Information is presented for each participant, thoracic (T), cervical (C), lumbar (L), cerebral 
palsy affecting all four limbs (CP). Values are means ± SD (n=8). 
 
 
 
 
 
Table 2 Participant Characteristics  
# code Years Since 
Injury 
¥Sport 
Classification Sport(s) 
Number of Years for 
Sport Involvement 
1 
23  Class 1 
Basketball, 
waterskiing 20, 18 
2 
28 Class 0.5 
Basketball, speed 
swimming 13  
3 
22  Class 1 
Basketball, track, 
skiing 13  
4 
0.5 Not known 
Track, weight 
training  1 month 
5 
8  Class 1 
Basketball, 
waterskiing 2 , 3  
6 25  Class 1 Rugby 23  
7 
23.5  Class 0.5  
Rugby, hand-
cycling, alpine ski 14, 5  
8 7  Not known Swimming 3  
Information is presented for each participant. ¥Sport classifications are from International 
Wheelchair Basketball Federation and International Wheelchair Rugby Federation. Class 0.5 
having higher level of SCI compared to Class 1.0 in sport classification.  
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2.2 Experimental Design 
The research project involved three testing stages. The first visit involved the completion 
of the consent form, the physical activity readiness questionnaire (PAR-Q) and a participant 
medical history form to determine current health status and medications. Copies of these 
forms can be found in Appendix III. The PAR-Q is a 1-page questionnaire for people 15 to 69 
years of age. It is used to assess whether individuals are physically ready to take on an 
exercise program. The first visit also included collection of body composition data using dual-
energy x-ray absorptiometry (DXA), VO2peak testing, and distribution of the modified 3-day 
food and exercise records. A 3-day food and exercise record modified for high performance 
athletes was used to control for the participant’s dietary intake and monitor activity level 
between the two exercise and performance trials. The 3-day modified food and activity record 
can be found in Appendix IV. The body composition information was used to determine 
percent body fat (%BF) and fat free mass (FFM). The participants’ VO2peak was determined 
using an adapted stationary hand cycle suited for wheelchair athletes. The first visit was also 
used as a familiarization trial and for setting the exercise intensity standards for the exercise 
and performance trials. The participants were randomly assigned under double blind 
conditions into two groups. Group 1 received the treatment during the first exercise trial and 
group 2 received the treatment during the second exercise trial.  
The second visit took place within approximately 7 days of the familiarization and 
maximal VO2 testing visit. The second and third visits included an exercise trial at 65% 
VO2peak for 1 hour followed immediately by a 30-minute performance trial. All of the exercise 
and performance trials were conducted on the same adapted stationary hand cycle as the 
VO2peak.  The second and third visits were held one week apart. During the performance trial 
33 
 
the participants were instructed to cover as much distance as possible. Blood glucose and 
blood lactate were measured before the exercise trial and at 20-minute intervals during the 1 
hour 65% VO2peak trial. The 8% CHO treatment and placebo beverages were provided during 
the 1 hour 65% VO2peak trial in 200 ml dosages at 15, 30, 45, and 60 minutes. A total of 800 
ml of fluids were provided during the 1 hour 65% VO2peak trial, providing 64 total grams of 
CHO. No beverages were provided during the 30-minute performance trial. 
 The physiological and metabolic impact of the moderate intensity exercise trial and 
performance trial was assessed through the collection of respiratory gases using a metabolic 
cart (Sensormedic Vmax 29 series; Anaheim, CA). Blood glucose and lactate were monitored 
immediately after the 30-minute performance trial and at 2, 5, and 10 minutes after the trial. 
Borg’s RPE scale was administered every 20 minutes during the 60-minute trial and 
immediately after the 30-minute performance trial. The final dependent variables that were 
analyzed were the performance measures of total distance (km), average speed (km·hr-1) and 
maximum speed (km·hr-1) achieved during the performance trial. These variables were 
compared between the exercise trials to identify any significant difference attributed to the 8% 
CHO beverage consumption. A full diagram of the experimental design can be found in 
Appendix V. 
 
2.2.1 Details of Anthropometric and Body Composition Collection  
 Collection of anthropometric and body composition data including body mass (kg), 
height (cm), skinfolds, and DXA took place during the first visit. Body mass was determined 
using a platform scale that measured mass to the nearest 0.05 of a kilogram. Arm span was 
used as an indirect measure of height and was measured to the nearest centimetre (Mahan & 
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Escott-Stump, 2000). Arm span was measured while the participants were in a seated position. 
Skinfold measures were taken from four sites on the right side of the body; specifically, 
biceps, triceps, suprailiac, and subscapular. The skinfold calipers that were used were 
Harpenden skinfold calipers (Baty International, West Essex, England). Each site was 
measured three times. The mean skinfold thickness score was used for analysis. The Durnin 
and Wormersley equation was used to determine the percent body fat (Durnin & Womersley, 
1974). These sites were selected based on a study by Wells & Hooker (1990) who found that 
these sites were the most appropriate when assessing body composition of athletes with an 
SCI.  
The DXA scan is a non-invasive test, which provides precise measurements of bone 
density, lean tissue mass, and total and regional body fat. Upon arrival for the DXA scan 
(Hologic Discovery QDR series Hologic Inc., Bedford, MA) the participants were asked to 
remove any metal accessories as these would impact the accuracy of the scan. Participants 
were instructed to lie in a prone position with the legs and arms extended as much as possible. 
One whole body scan was conducted for each participant. A technician carried out each DXA 
scan. The DXA unit uses very low dose x-rays of two different levels to distinguish between 
bone and soft tissue. DXA has been used to assess the body composition of wheelchair 
athletes in previous research (Mojtahedi, Valentine, & Evans, 2009; Maggioni, Bertoli, 
Margonato, Merati, Veicsteinas & Testolin, 2003). Mojtahedi et al. (2009) used the DXA scan 
as a reference method in comparison to skinfold and bioelectrical impedance analysis (BIA) 
with a group of 16 athletes with an SCI. They reported that DXA has been shown to be an 
accurate method for assessing body composition in this population (Mojtahedi et al., 2009). 
Jones et al. (1998) used DXA to assess changes in body composition in males with paraplegia. 
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They stated that DXA can be used to quantify body composition accurately in SCI participants 
(Jones et al., 1998). 
 
2.2.2 Details of 3-day Food and Activity Records 
The primary goal of the 3-day food and activity records was to control for training and 
food intake leading into both exercise and performance trials. The participants were asked to 
maintain their normal training schedule and food intake patterns prior to and during the 
research study. The 3-day food and activity record can be found in Appendix IV. The 
participants were provided with verbal instructions by a registered dietitian on how to 
complete the 3-day food and activity records. The 3-day food record was modified to meet the 
needs of an athlete, by increasing space for recording larger portions, allowing more space for 
snack foods and fluids, and including questions regarding supplement use (Lun, Erdman, 
Reimer, 2009). The 3-day food record had been developed and used to collect dietary data 
from Canadian athletes (Lun et al. 2009) Developing the 3-day food records specific to 
participant needs was done in an effort to reduce the likelihood of error when completing the 
record (Block & Hartman, 1989). Previous researchers have used a one meal record and a 3-
day food record as their dietary control (Spendiff & Campbell, 2003, 2004, 2005). The 
methods used in this research study imposed more control over dietary intake and physical 
activity, the rationale being that glycogen content may be impacted by an individual’s 
food/fluid intake and physical activity in the days leading up to and between the exercise 
trials. The participants were asked to record their complete intake in detail, time consumed, 
amounts, types of foods, brand names, types of fluids, for the three days prior to the first 
exercise trial. The record was then used as a guide for three days prior to the second exercise 
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trial.  The food records were analysed using FUEL 2.3b standard software (LogiForm 
International Inc., Saint-Foy, Quebec, Canada) for total energy content, carbohydrates, 
protein, fats and total fluids by a registered dietitian. The FUEL software has been used in 
previous published research to assess energy and macronutrient intake (Belanger & Boulay, 
2005; Bruner, Chad, & Chizen, 2006).  
The 3-day activity record was used to control for physical activity between the exercise 
trials and not for an estimation of energy expenditure. The participants were asked to record 
any physical activity conducted during the three days prior to the exercise and performance 
trial. They were then provided with a copy of their 3-day record, and they were encouraged to 
follow the same activity patterns prior to the second exercise and performance trial. 
 
2.2.3 Protocol for the Maximal Oxygen Uptake Test (VO2peak) 
Each participant’s VO2peak was measured using a stationary adapted hand bike (Varna II 
with a Cateye Tomo XC, CC-ST200 bike computer; Garbiola Island, BC, Canada). Expired 
gases were collected using a metabolic cart (Sensormedic Vmax 29 series; Anaheim CA). The 
resistance on the bike was held constant for all participants. After a 5-minute warm up, the 
VO2 protocol started at an initial velocity of 4 km·h-1 for 1 minute and then increased by 1 
km·h-1 every minute until exhaustion. The speed (km·h-1) was measured with the Cateye bike 
computer. Heart rate, VO2 and VCO2 were continuously monitored throughout the testing 
protocol. Pre and post lactate tests were also taken. Criteria used to determine if VO2peak was 
attained were a RER (VCO2·VO2 -1) level above 1.10, a heart rate that meets or exceeds 95% 
of their age-predicted heart rate maximum of  220 - chronological age (Vinet et al.2002), and 
participant inability to sustain the required velocity despite verbal encouragement (Fukuoka, 
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Endo, Kagawa, Itoh, & Nakanishi, 2002). Exhaustion was noted as the point at which the 
participant could not maintain the speed (km·h-1). The participants were also familiarized with 
the testing procedures for both blood glucose and blood lactate during the VO2peak testing.  
 
 
2.2.4 Protocol used for Group Assignments 
A research assistant, otherwise not involved with the research project, coded the 
participants by number. The code system was kept blind to the primary researcher until the 
completion of data collection and statistical analysis. The participants were separated by 
gender and then each gender was placed into two groups by random selection under double 
blind conditions. The participant codes were then drawn at random. The participants were 
then placed into either group one or group two. This method was used to ensure that the 
gender distribution was equal between both groups. Previous research has found that the 
hormonal fluctuations that occur during the female menstrual cycle may impact glycogen 
utilization during exercise. The female participants were asked about their menstrual cycle in 
order to account for the impact of hormonal fluctuations. Half of the group (n=4) received the 
treatment first and the other half (n=4) received the placebo first. The placebo was used to 
increase the internal validity of the research study, as it evaluated whether the observed effect 
is produced by the treatment or psychological effect (Thomas, Nelson, & Silverman, 2005). 
The two exercise trials were held approximately seven days apart (7 ± 1 day).  
 
2.2.5 Carbohydrate Beverage Protocol 
A research assistant, not otherwise involved in the study, measured the treatment and 
placebo powders to ensure that neither the researcher nor the participants were aware of the 
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beverage composition. The CHO beverage was 200 ml of an 8% CHO (8 g of CHO per 100 
ml of water) ingested every 15 minutes during the 1 hour trial (at the 15, 30, 45, 60 minute 
mark) for a total of 64 g of CHO. The total composition for the 800 ml of 8% CHO beverage 
was 42.2 g sucrose, 21.1 g glucose, 448 mg sodium, and 139 mg potassium (Orange, 
Gatorade, Pepsico, Inc.). The placebo beverage contained 1.6 g sucrose, 160 mg sodium and 
48 mg potassium per 800 ml. The placebo beverage was the same color and contained a non-
caloric sweetener, sucralose (Orange, Nestea Acitv, Splenda© brand). The CHO and placebo 
beverage were matched for taste to the best of our ability. An 8% CHO was used based on 
previous research by Spendiff and Campbell (2004) in which they used a 7.6% CHO solution 
(7.6 g of CHO per 100 ml water), a total 49 g of CHO, and found a non-significant 
performance benefit. The protocol utilized in this study provided a greater volume of beverage 
and a greater amount of CHO than previous work. This increased dosage addresses the 
limitations noted from the Spendiff and Campbell (2004) study in an attempt to enhance the 
effect on the performance measure. The 8% CHO beverage that was provided in 200 ml 
dosages every 15 minutes was also designed to meet the upper limits of the 2000 ACSM, 
ADA, DC carbohydrate guidelines for able-bodied athletes of 30 to 60 g CHO per hour 
(approximately 0.7 g CHO·kg-1·h). An ideal CHO dosage has yet to be determined for 
wheelchair athletes. The high end of the dosage range was also used because previous 
research conducted with individuals with SCI has noted that fat oxidation is limited during 
aerobic exercise (Astorino & Harness, 2009). The dosage would provide 0.9 ± 0.2 g CHO·kg-
1, which exceeds the recommendations; however, this dose was the only fuel source for the 
60-min exercise and 30-minute performance trial. No feeding occurred during the 
performance trial.  
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2.2.6 Pre-Exercise Meal Protocol 
The participants were asked to report to the test site at the same time on both occasions 
following a macronutrient-controlled meal that provided between 2 g CHO·kg-1 according to 
the IOC pre-exercise recommendations. Each participant was provided with a detailed list of 
what to consume in regards to certain food portions to meet their CHO needed based on their 
current body weight. Examples of pre-exercise meals are found in the Appendix VI. The 
macronutrient-controlled meal was consumed 3 hours prior to the exercise test. This protocol 
helped ensure that the participants were not starting in a fasted state, which may have led to 
premature fatigue and decreased baseline blood glucose levels.  
 
2.2.7 Expired Gas Collection and Blood Sample Analysis  
Expired gases were collected at 5-minute intervals during the 60-minute exercise trial 
65% VO2peak (0-5 min, 15-20 min, 30-35 min, 40-45 min, 55-60 min) and continuously during 
the 30 minute performance trial. Total CHO and fat oxidation (g·min-1) was calculated using 
the following equations (Jeukendrup & Wallis, 2005); 
Total CHO oxidation (g·min-1) = 4.210VCO2 – 2.962VO2  
Total fat oxidation (g·min-1) = 1.695VO2 – 1.701VCO2  
Respiratory exchange ratio was calculated during the exercise and performance trials as 
the ratio between the volume of CO2 expired and the volume of O2 consumed.  
Heart rate was monitored throughout the trial using both the metabolic cart and a Polar 
watch monitor (Polar CE0537, Polar Electro OY, Finland). Blood glucose and blood lactate 
were measured prior to the exercise trial, at 20 min interval during the 65% VO2peak exercise 
phase, immediately post and at 2, 5 10 min after the 30-minute performance trial. A fingertip, 
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selected by the participant, was first cleaned with an alcohol swab. The fingertip was then 
pricked and a drop of blood was put on a glucose test strip and a subsequent drop on a lactate 
test strip. Samples were subsequently assessed for glucose using a One Touch® Ultra MiniTM 
portable glucometer (LifeScan/ Johnson & Johnson, Milpitas, CA, USA) and for lactate using 
the Lactate Pro, portable lactate meter (Arkray, Inc., Kyoto, Japan).  The glucose One Touch 
Ultra® test strips that were used can measure blood glucose levels in the range of 0.6 to 33.3 
mmol.l-1 (according to manufacture specifications). A meter that can read low blood glucose 
values is critical when monitoring values during exercise using a placebo non-caloric 
beverage because hypoglycaemia could occur (<2.5 mmol.l-1). The blood glucose meters and 
testing strips were selected because they are portable and requires only a small (0.6 µl) 
quantity of blood. 
The Lactate Pro was used because it requires a small sample of blood; only 5 µl is 
needed on the reagent strip. Pyne, Boston, Martin, and Logan (2000) evaluated the reliability 
and versatility of the Lactate Pro analyser with elite athletes from the Australian Institute of 
Sport. The correlation between the Lactate Pro and the ABL 700 Series Acid-Base analyser, 
considered to be the criterion instrument, was r = 0.98. The correlation between two Lactate 
Pro analysers on the same sample (n = 96 cases) was r = 0.99 (Pyne et al., 2000). Pyne et al. 
also noted that the Lactate Pro can analyse a sample and display the results approximately 30 
seconds quicker than other portable lactate monitors, which makes it more desirable for field 
testing. The Lactate Pro has been used with this population in previous research (Goosey-
Tolfrey, Foden, Perret, & Degens, 2008). All analysers were calibrated and operated in 
accordance with manufacturer’s instructions.  
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2.2.8 Exercise and Performance Trial 
All the participants completed the same exercise and performance trial. The exercise and 
performance trial was conducted on an adapted stationary hand cycle. A full diagram of the 
exercise, CHO feeding and sample collection protocol can be found in Appendix V. The 
exercise trial was 1 hour at 65% VO2peak followed immediately by a 30-minute performance 
trial in which distance covered (km), average speed (km·h-1) and maximum speed (km·h-1) 
were measured. This exercise protocol was different from that used in previous research. Prior 
studies included a 5-minute rest between the one hour exercise trial and the performance trial. 
This change in protocol ensured that the exercise and performance trial were more consistent 
with real world sport competitions, in which no breaks are provided prior to the finishing 
sprint or increase in intensity. An exercise intensity of 65% VO2peak was chosen because it has 
been shown to elicit an increase in the reliance on CHO as the primary fuel source during 
wheelchair racing (Knechtle, Muller, Willmann, Eser & Knecht, 2004). Also, Spendiff and 
Campbell (2004) noted that exercise trials at intensities above 65% VO2peak might result in 
premature fatigue during the 1-hour trial. The performance trial was set at 30 minutes to 
reflect the participant’s competitive events. Most of the cross country ski competitions occur 
over 30 to 50 minutes, wheelchair basketball is played over four 10-minute quarters, and 
wheelchair racing athletes compete in sprint events (100 m, 200 m, 400 m), middle distance 
(800 m, 1500 m), and long distance (5,000 m, 10,000 m) events. Depending on the 
participant’s fitness level the 10,000 m wheelchair event can take between 30 to 40 minutes. 
Previous research also stated that results in a longer performance trial, more than 20 minutes, 
might be impacted to a greater degree by CHO feedings (Spendiff & Campbell, 2005).  
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Borg’s scale of rating of perceived exertion was also administered at the 20, 40, 60-
minute mark of the 65% VO2peak exercise trial and at the completion of the 30-minute 
performance trial. Borg’s scale of RPE is a 15-grade scale of perceived exertion, with values 
from 6 to 20. The RPE scale is a widely accepted means of estimating exercise intensity in 
adults (Lamb, Eston, & Corns, 1999). A rating of 6 to 7 on the scale corresponds to a very, 
very light effort, and a rating of 19 to 20 indicates an RPE of very, very hard effort (Borg, 
1982). “The overall perceived exertion rating integrates various information, including the 
many signals elicited from the peripheral working muscles and joints, from the central 
cardiovascular and respiratory functions, and from the central nervous system” (Borg, 1982, 
p.377). The RPE scale correlates with heart rate (r = 0.80 to 0.90) (Borg, 1982).  
 
2.3 Statistical Analysis 
  Sample size was calculated using a power of 80% and the effect size of 0.72 noted from 
the performance measures of a study conducted with a similar population group (Spendiff & 
Campbell, 2003). A sample of 15 participants was needed to have sufficient statistical power. 
Sixteen participants were initially recruited. Four participants did not complete the study due 
to their work schedule. Two participants had to withdraw after the body composition testing 
due to pre-existing injuries not related to the study. Two participants did not live in Saskatoon 
and the time and travel commitments for the exercise and performance testing was too much 
of a time commitment. Eight participants completed all of the components of the research 
study. 
The impact of the independent variable, CHO beverage consumed, on the dependent 
variables (RER, HR, blood lactate, blood glucose, and RPE) between the exercise trials was 
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analyzed for significance using a two factor repeated measures ANOVA. The statistical 
analysis program used in the current study was SPSS 16.0 (SPSS Inc. Headquaters, Chicago, 
IL). If there was a violation of sphericity, the Greenhouse-Geisser values were used. T-tests 
with bonferonni adjustments were used for post hoc analysis when needed. A dependent t-test 
was used to analyze the performance measure, distance covered, between the two 30-minute 
performance trials. Dependent t-test was also used to test for an order effect between the two 
trials. A significance of p<0.05 was used.  
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CHAPTER 3 
 
3. RESULTS 
3.1 Body Composition  
As evident in Table 3, % BF did not differ significantly across the two methods 
of measurement (DXA and skinfold measures) of determination, t(7) = -1.905,  p=0.099.  
Table 3- Body Composition Data 
 
# Code % BF- skinfold DXA- % BF 
 
DXA LBM (kg) 
 
BMD (g·cm2) 
1 34.3 33.6 48.3 1.23 
2 21.3 23.4 52.2 1.17 
3 32.5 36.9 30.4 1.83 
4 27.8 26.8 63.5  1.25 
5 21.3 24.0 63.2  1.53 
6 13.6 13.4 52.4 1.16 
7 32.3 32.9 55.0 1.10 
8 31.5 38.5 49.7  1.26 
Means 
± SD 
26.8 ± 7.3 
(M) 25.1 ± 7.1 
(F) 32.1 ±  0.5 
 
28.7 ± 8.4 
(M) 25.7 ± 6.8 
(F) 37.7 ± 0.8 
 
51.8 ± 10.4 
(M) 55.8 ± 5.7 
(F) 40.1 ± 9.7 
 
1.32 ± 0.24 
(M) 1.24 ± 0.14 
(F) 1.55 ± 0.28 
Lean body mass (LBM), percent body fat (% BF), bone mineral density (BMD). Means 
± SD are presented for the group (n=8) and by gender, females (F) (n=2), males (M) 
(n=6). 
 
3.2 Three Day Food Records 
 Results from the modified food records are presented in 3-day averaged values 
(Table 4). Total caloric intake and caloric intake per kg body weight are presented for 
each participant. Data presented from the 3-day food records were compared to, ADA, 
ACSM, and DC (2000) guidelines. Only 25% of the participants met the daily caloric 
recommendations for active adults (active = 37 to 41 kcal·kg-1 body weight·d-1). 
Macronutrients were analysed relative to body weight (g·kg-1body weight·d-1) and 
compared to current able-bodied athlete and active adult guidelines. Carbohydrate 
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recommendations of 6 to 10 g·kg-1 body weight·d-1 were not met by any of the 
participants. Protein recommendations for able-bodied athletes and active adults of 1.2 
to 1.7 g·kg-1 body weight·d-1 were met by 63% of the participants. Average caloric 
intake from fat (31%) exceeded current recommendations of 20-25% total energy intake. 
Total fluid intake was below gender specific recommendations of 3,700ml for males and 
2,700ml for females. The participants were also asked to report their supplement use. 
Three of the participants reported taking supplements including: multivitamins, vitamin 
D, E, and folic acid.   
Table 4- Three-day Food Record Values 
# Code  kcal 
intake 
kcal·kg-1 
BW 
CHO g·kg-1 
BW 
Protein g·kg-1 
BW 
% kcal 
fat 
Total 
fluids (ml) 
1 2622  33  4.20  1.12 35 2047 
2 2779  38.6  4.10  1.87 39 2167 
3 1629  31  4.26  1.49 27 1517 
4 2749 29.7  4.17  1.56 21 2787 
5 3096 36.5  4.65  1.92 30 1978 
6 2740 40.3  4.82  2.18 30 3660 
7 1808 20 2.41  0.83  37 2383 
8 2086  23.6  3.53  0.76  29 2683 
Mean ± 
SD 
2438 ± 
528 
31.6 ± 
7.1 
4.02 ± 0.75 1.46 ± 0.52  31 ± 5.8 2403 ± 
650 
Information is presented for each participant. Energy (kcal), macronutrients and total 
fluids are presented. Values are means ± SD (n=8). Data presented are 3-day averaged 
results. 
 
3.3 Maximal Exercise Measures 
The average VO2peak achieved was 1.49 ± 0.49 l·min-1, and average heart rate, 
RER and CHO oxidation achieved at peak were 145 ± 27 bpm, 1.25 ± 0.103 and 3.38 ± 
1.12 g·min-1 respectively. Lactate at pre-test and at the completion of the maximal effort 
was 1.45 ± 0.5 mmol.l-1 and 7.35 ± 2.33 mmol.l-1. The results are presented for each 
participant in Table 5. 
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 Table 5- Participants’ Resting Heart Rate Values and Maximal VO2peak Testing 
Values  
#
  
Resting 
HR 
Max 
HR 
Max 
Speed 
(km·h-1) 
Pre-lactate  
(mmol.l-1) 
Post-
lactate 
(mmol.l-1) 
VO2 peak 
(l·min-1) 
VO2peak 
(ml·kg·mi
n-1) 
RER  
1 84 171 17 1.9 12.9 1.728 22.6 1.36 
2 78 171 12 1.3 5.8 1.993 27.7 1.13 
3 90 120 12 0.8 7.7 0.988 18.7 1.24 
4 83 171 18 1.6 8.2 2.469 26.6 1.21 
5 81 165 14 1.8 6.7 1.295 15.4 1.37 
6 70 109 11 1.1 5.0 1.128 16.5 1.07 
7 71 108 11 1.0 5.6 1.135 12.5 1.25 
8 70 148 11 2.4 6.9 1.196 13.5 1.35 
 78.4 ± 
7 
145 ± 
27 
13 ± 2.6 1.5 ± 0.5 7.4 ± 2.3 1.49 ± 0.49 19.2 ± 5.5 1.25 ± 
0.10 
Information is presented for each participant. Heart rate (HR), respiratory exchange ratio 
(RER). Values are expressed as means ± SD (n=8). 
 
3.4 Menstrual Cycle Timing 
 Both female participants completed the CHO beverage exercise trial during the 
luteal phase and the placebo exercise trial during the follicular phase. Participant 3 
conducted the CHO beverage trial on day 28 of her menstrual cycle and the placebo trial 
on day 7 of her menstrual cycle. Participant 8 conducted the CHO beverage trial on day 
25 of her menstrual cycle and the placebo trial on day 4 of her menstrual cycle. 
Carbohydrate ingestion did not enhance the performance of either athlete and their 
results followed the same trend as the male participants. Therefore the mean values 
presented are not separated by gender. 
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 3.5 Exercise Trial Physiological Measures 
3.5.1 Respiratory Exchange Ratio (RER) 
 During the 60-minute exercise trial there was a significant interaction between 
beverage and time, F(1.712, 11.985)= 5.55 p=0.023. RER values were significantly 
higher in the CHO beverage trial during the final collection period of the 60-minute 
exercise trial (55-60 minutes). For the performance trial there was a significant beverage 
by time interaction, F(5,30)= 3.22, p=0.019. During the final 10 minutes of the 
performance trial RER values were also significantly higher during the CHO beverage 
trial versus the placebo trial p<0.05. Individual RER values can be found in Appendix 
IX. Mean values are presented in Figure 1 and Table 6.  
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Figure 1. Mean Respiratory exchange ratio (RER) ± SD values during the collection periods, 0-5 
min,15-20 min, 30-35 min, 40-45 min, 55-60 min for the 60-min exercise trial (n=8). Collection 
periods were 5-min averages during the 30-min performance trial. * Indicates that the CHO 
beverage trial RER values were significantly higher during the 55-60-min collection period and 
the last 2 collection periods of the performance trial (20-25 minutes and 25-30 minutes) (p<0.05). 
For the final collection period, 85 to 90-min (n=7). 
3.5.2 Carbohydrate Oxidation (g·min-1) 
 For the 60-minute exercise trial, there was no significant main effect of the 
beverage and no significant main effect of time (p=0.087). There was no significant 
beverage by time interaction (p= 0.062). For the 30-minute performance trial there was a 
significant beverage by time interaction, F(5,30)= 3.862, p=0.022. Post hoc analysis 
revealed that there was a significant difference in CHO oxidation values during the last 5 
minutes of the performance trial, t(6)= 3.884, p=0.008. The CHO beverage trial resulted 
in a higher oxidation value (2.07 ± 1.02) vs. the placebo trial (1.88 ± 1.01). The data 
points are presented in Figure 2. 
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 Figure 2. Average carbohydrate (CHO) oxidation (g·min-1) ± SD values during the 
collection periods, 0-5 min,15-20 min, 30-35 min, 40-45 min, 55-60 min for the 60-min 
exercise trial (n=8). Collection periods were 5-min averages during the exercise and 
performance trial. For the final collection period, 85 to 90-min (n=7).* Indicates the 
CHO beverage trial resulting in significantly more CHO oxidation during the last 5 
minutes of the performance trial (p<0.01). 
 
3.5.3 Oxygen Uptake (VO2)  
 For the 60 minute exercise trial there was a significant effect of time, F(4,28)= 
15.77, p=0.00. There was no main effect of beverage and no significant interaction 
(p=0.257). For the performance trial there was a significant effect of time, 
F(1.168,7.006)= 14.31, p=0.006. There was no significant main effect of beverage and 
no significant beverage by time interaction (p=0.296). The values are presented in Table 
6. The percent VO2peak values are presented per participant for the 60-minute exercise 
portion and 30-minute performance trials are presented in Appendix VIII. 
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 Table 6- Physiological values collected during the 60-minute exercise (5-min time period averages) and 30-minute 
performance trial (continuous sampling, 5-min averages) for CHO beverage trial and placebo beverage trial.  
Time VO2 (l·min-1)#  RER CHO oxidation (g·min-1) Fat oxidation (g·min-1) 
 
 
   CHO            Placebo    CHO               Placebo   CHO             Placebo   CHO             Placebo 
0-5 min 
 
0.78 ± 0.2      0.73 ± 0.2 0.99 ± 0.04    0.99 ± 0.04 0.96 ± 0.4        0.92 ± 0.4 0.02 ± 0.03      0.14 ± 0.03 
15-20 min 
 
0.79 ± 0.2      0.82 ± 0.3 0.95 ± 0.03    0.96 ± 0.04 0.83 ± 0.3        0.93 ± 0.5 0.06 ± 0.03      0.12 ± 0.02 
30-35 min 
 
0.83 ± 0.2      0.84 ± 0.3 0.96 ± 0.02    0.94 ± 0.04 0.88 ± 0.2        0.85 ± 0.4 0.06 ± 0.02       0.07 ± 0.04
40-45 min 
 
0.85 ± 0.2      0.89 ± 0.3 0.96 ± 0.02    0.94 ± 0.04 0.92 ± 0.3        0.90 ± 0.5 0.05 ± 0.04      0.08 ± 0.05 
55-60 min 
 
0.93 ± 0.3      0.94 ± 0.3 0.99 ± 0.03*  0.94 ± 0.04 1.12 ± 0.3        0.86 ±0.6 0.03 ± 0.03      0.08 ±0.04 
Time-1 
 
0.98 ± 0.3      1.03 ± 0.4 0.98 ± 0.04    0.96 ± 0.06 1.16 ± 0.4        1.17 ± 0.5 0.04 ± 0.04      0.04 ± 0.04 
Time-2 
 
1.06 ± 0.3      1.09 ± 0.4 1.00 ± 0.03    0.97 ± 0.06 1.33 ± 0.4        1.32 ± 0.6 0.03 ± 0.04      0.05 ± 0.04 
Time-3 
 
1.15 ± 0.3      1.12 ± 0.4 1.01 ± 0.05    0.99 ± 0.05 1.41 ± 0.5        1.44 ± 0.7 0.03 ± 0.03      0.03 ± 0.04 
Time 4 
 
1.14 ± 0.4      1.16 ± 0.4 1.02 ± 0.07    0.99 ± 0.07 1.36 ± 0.5        1.45 ± 0.6 0.03 ± 0.04      0.05 ± 0.06 
Time 5 
 
1.27 ± 0.4      1.29 ± 0.5 1.04 ± 0.09*    1.0 ± 0.10 1.64 ± 1.0       1.39 ± 0.6 0.02 ± 0.02      0.08 ± 0.07 
Time 6 
 
1.32 ± 0.5      1.32 ± 0.5 1.06 ± 0.10*    1.0 ± 0.10 2.07 ±1.03*     1.88 ± 1.0 0.01 ± 0.02      0.02 ± 0.05 
5
1
 
Values are presented as mean ± standard deviation.  *Indicates values were significantly higher in the CHO beverage trial vs. 
placebo trial (p<0.05). Values for 60-min exercise trial (n=8), for performance trial (n=7). # Indicates a significant increase in 
VO2 values during the 60-minute exercise and 30 minute performance trial (p<0.05) but no significant differences between 
the beverage trials.
 
  
3.5.4 Fat Oxidation (g·min-1) 
 For both the 60-minute exercise trial and the 30-minute performance trial there 
was no significant interaction, main effect of time or main effect of drink (Table 6).  
 
3.5.5 Heart Rate  
During the 60-minute exercise trial there was no effect of beverage or time on 
heart rate and no significant interaction. At the end of the 60-minute exercise trial the 
average heart rate values were 111 ± 18 bpm for the CHO beverage trial and 106 ± 20 
bpm for the placebo trial.  For heart rate during the 30-minute performance trial there 
was a significant main effect of time, F (1.156, 6.938) =11.994, p=0.009. An increase in 
heart rate over time during the performance trial occurred as expected. At the end of the 
performance trial the heart rate values were 138 ± 27 bpm for the CHO beverage trial 
and 134 ± 26 bpm for the placebo trial. Values are presented in Figure 3. 
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Figure 3. Average heart rate ± SD values (bpm) during the collection periods, 0-5 
min,15-20 min, 30-35 min, 40-45 min, 55-60 min for the 60-min exercise trial (n=8). 
Collection periods were 5-min averages during the 30-min performance trial. For the 
final collection period, 85 to 90-min (n=7).There was no significant effect of time during 
the 60 minute exercise trial. # Indicates a significant increase in HR during the 30 
minute performance trial (p=0.009) but no significant differences between the beverage 
trials. 
# 
 
3.6 Finger Tip Capillary Blood Analyses 
3.6.1 Glucose (mmol.l-1) 
 For the blood glucose values there was a significant beverage by time interaction 
for both the 60-minute trial and the performance test (Figure 4). The CHO beverage trial 
resulted in higher blood glucose values at 40 and 60 minutes and at the end of the 
performance test. At the end of the performance trial the values were significantly higher 
in the CHO beverage trial (p= 0.008), with 4.83 ± 1.26 mmol.l-1 for the CHO beverage 
trial vs. 4.03 ± 0.49 mmol.l-1 for placebo trial. Individual blood glucose values can be 
found in Appendix IX. 
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 Figure 4. Mean blood glucose values (mmol.l-1) ± SD collected at 8 time points (n=8), 
pre-exercise trial, at 20-min, 40-min, 60-min and then immediately post 30-minute 
performance trial, 2-min, 5-min and 10-min post. * Indicates significantly higher blood 
glucose values in the CHO beverage trial vs. the placebo beverage (p<0.05). 
*
*
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3.6.2 Lactate (mmol.l-1) 
 For blood lactate values there was a significant main effect of time (p=0.02). 
There was no significant main effect of beverage (p=0.082) and no significant beverage 
by time interaction (p= 0.537). Lactate values are presented in Table 7. Individual lactate 
results can be found in Appendix IX. 
 
3.7 Rating of Perceived Exertion (RPE)  
 During the exercise and performance trial, the RPE values increased over time, 
as was expected, F(3,21)= 60.78, p<0.001. There was no significant main effect of 
beverage (p=0.339) and no significant beverage by time interaction (p=0.723). Values 
are presented in Table 7. 
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Table 7- Blood Lactate, Glucose and RPE values during the 60-minute exercise trial 
and post 30-minute performance trial 
Time 
points 
#Blood Lactate (mmol.l-1) Blood Glucose (mmol.l-1) #RPE values 
 CHO              Placebo CHO           Placebo  CHO                   Placebo 
Pre-test 
 
1.9 ± 0.8           1.5 ± 0.6  4.9 ± 0.6          5.7 ± 0.6  
20min 
 
3.7 ± 2.0           4.3 ± 2.6  4.7 ± 0.7          4.9 ± 1.0 11.3 ±  1.6          11.5 ±  1.1 
40min 
 
4.1 ± 2.6          3.1 ± 1.6  5.8 ± 0.7*        4.7 ± 0.6 12.3 ±  1.6          12.8 ±  1.0 
60 min 
 
5.8 ± 6.8          3.7 ±  3.2 6.3 ± 1.0*         4.5 ± 0.7 13.1 ±  1.8          13.6 ±  1.7 
Post Perf. 
 
6.8 ± 2.9          7.2 ±  4.7 4.8 ±1.3*         4.0 ± 0.5 18.5 ±  1.7          18.5 ±  1.8 
2min post 
 
7.7 ± 5.9          8.3 ± 7.8 4.4 ± 0.5          4.6 ± 1.2  
5min post 
 
7.3 ± 4.4          6.0 ±  6.0 4.8 ± 0.8          4.4 ± 0.5  
10min 
post 
 
4.6 ± 2.3          3.6 ± 2.2 4.6 ± 0.3          4.4 ± 0.3  
* Indicates a significant difference between the 2 trials (p<0.05). RPE, rating of perceived 
exertion. # Indicates a main effect of time for blood lactate values and RPE (p<0.05). 
Values presented are means ± SD (n=8). 
 
3.8 Exercise Performance Measures 
There were no significant differences between the CHO beverage trial and placebo trial 
for distance covered (CHO beverage 5.25 ± 1.22, placebo trial 5.32 ± 1.26 km), average 
speed (CHO beverage 10.80 ± 2.43, placebo trial 10.90 ± 2.43 km·h-1), or maximal 
speed (CHO beverage 14.43 ± 3.45, placebo trial 14.64 ± 3.25 km·h-1) during the 30-
minute performance trial. There was a significant correlation between the two 
performance trials for total distance (km) (r= 0.994). Those athletes that covered the 
greatest distance during the CHO beverage trial also achieved a greater distance during 
the placebo trial. One participant was not able to complete the full 30-minute 
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 performance trial; he had to stop at 22:33.00 due to fatigue. Therefore the second 
performance trial was limited to 22:33.00 to ensure that performance measures could be 
compared. Total distance for the CHO beverage trial and placebo trial are presented in 
Figure 5. The performance distances are presented for each participant for the 60-minute 
exercise trial in Appendix VIII. Individual performance trial results can be found in 
Appendix IX. 
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Figure 5. Mean group distance ± SD covered in 30-minute performance trial, no 
significant differences between trials. CHO beverage trial distance was 5.25 ± 1.22 km, 
Placebo trial distance was 5.32 ± 1.25 km (n=8). 
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 CHAPTER 4 
 
 4. DISCUSSION  
 
Results from this study failed to demonstrate any significant differences between the 
CHO beverage and placebo for total distance (km), average speed (km·hr-1) or maximum speed 
achieved (km·hr-1) during the 30-minute performance trial following 1 hour of exercise at 65% 
VO2peak. Only two of the eight participants covered more distance during the CHO beverage 
trial versus the placebo trial. We also found that the 8% CHO beverage did not result in lower 
RPE values during the exercise or performance trial. Our hypotheses that the CHO beverage 
would result in higher blood glucose and RER values in addition to greater CHO oxidation 
during the exercise and performance trial were supported. The results from the 3-day foods 
records indicated the participants were not meeting the current dietary recommendations for 
able-bodied athletes, the participants were within the AMDR and the RDAs for CHO and 
protein. 
 
4.1 Participant Characteristics 
 Each individual with a SCI has a unique level of function directly associated 
with the nature and specific level of their spinal cord injury. The level of SCI, whether 
the injury is complete or incomplete and the nature of the resulting physical disability 
has a significant impact on the physiological response of the individual to exercise and 
overall physical capacity (Bhambhani, 2002). In a study examining 68 athletes with a 
variety of spinal cord injury levels and physical impairments van der Woude, Bouten, 
Veeger and Gwinn (2002) noted that physiological characteristics are highly variable 
even within participant groups with the same categorized injury levels due to individual 
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 variations in neurological function, sport discipline and other personal traits. Therefore, 
it is important to recognize that making comparisons with data from the current study 
with others examining wheelchair athletes has numerous limitations. It is also important 
to note that one of the participants in the current study has cerebral palsy (CP) which has 
also been shown to affect maximal exercise capacity (van der Woude et al., 2002) but in 
a manner dissimilar to what would be expected for individuals with a SCI.  
 Measures of physical fitness, such as VO2peak, are significantly reduced in persons 
with a SCI when compared to values observed in healthy age-matched non-SCI 
individuals. The magnitude of this decrease is directly dependent upon the level of SCI 
(van der Woude et al., 2002) and the consequent physiological and physical impairments 
that occur. With a SCI above T1, as seen with two of the participants in the current 
study, sympathetic stimulation to the myocardium is affected, which reduces the 
individual’s maximal cardiac output leading to a reduction in overall oxygen 
transportation to the active tissue (Bhambhani, 2002). Other factors that lead to reduced 
VO2peak are a reduction in active muscle tissue below the level of lesion which limits 
arteriovenous oxygen difference and increased venous pooling in the lower extremities 
due to the loss of muscle pump action. Decreased muscle pump action causes a 
reduction in stroke volume and cardiac output due to reduced venous return to the heart 
(Bhambhani, Burnham, Wheeler, Eriksson, Holland & Steadward, 1995).  
 Five of the participants in the current study had injury levels ranging from T1 to 
L1. Their level of injury may have also resulted in decreased stroke volume and cardiac 
output due to the above factors minus the absence of sympathetic innervation, which 
may help to explain the low maximal oxygen uptake values which were observed. These 
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 participants had maximal heart rate values of 155 ± 19 bpm and maximal VO2 values of 
19.4 ± 4.8 ml·kg·min-1. 
 Although the participants in our study were trained athletes they did present, on 
average, with lower levels of fitness than might be expected as demonstrated by reduced 
VO2peak values. Wells and Hooker (1990) stated that VO2peak seems to be inversely 
related to the level of SCI, with the higher the SCI the lower the VO2peak. These findings 
are supported by the results of the current study in that the two participants with 
quadriplegia had very low VO2peak values of 14.5 ± 2 ml·kg·min-1. Bhambhani et al. 
(1995) reported maximal oxygen uptake values of 19.8 ± 4.3 ml·kg·min-1 for endurance-
trained male athletes with quadriplegia and studies specifically assessing athletes with 
paraplegia have demonstrated values 1.5 times greater than were observed in the current 
study (Price & Campbell, 1999). One key difference between the current study and the 
research done by Price and Campbell (1999) is the age difference of the participants. 
The mean age in the current study was 36 ± 8.5 years versus 28.5 ± 4.5 years in Price 
and Campbell’s participant group. Research conducted with able-bodied participants has 
found a direct impact of aging on the cardiorespiratory system. Maximal cardiac output, 
which is a major determinant of systemic oxygen transportation, decreases with age 
(Proctor, Beck, Shen, Eickhnoff, Halliwill & Joyner, 1998).  
 Training years may also be an important factor when looking at the variability in 
VO2peak values. The current study had a large range for duration of sport participation, 
from 23 years to 1 month, which could account for the large dispersion in many of the 
values presented. Price and Campbell (1999) did not present the individual values for 
training years. Therefore a comparison is not possible. Another factor that may have 
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 contributed to large variations in peak VO2 values within the sample is that the current 
study had two female participants, who had low values. The mean peak VO2 value for 
the male participants was 20.2 ml·kg·min-1, which slightly increases the mean value of 
the entire sample but does not account for all of the differences seen with the current 
population.  
For female athletes with a SCI, reports in the literature of aerobic data are very 
limited. Data available on four female athletes with T2 SCI showed the following: 
HRpeak 137.5 ± 38.7 bpm, VO2peak 0.73 ± 0.22 l·min-1 and RER values of 1.07 ± 0.19 
(van der Woude et al., 2002). The two female participants in the current study had 
similar maximal values despite the range in SCI from T1 to T12-L1. Schmid et al. 
(1998) focused specifically on the physiological status of female athletes with an SCI. 
Their results in regards to maximal VO2 are much higher than the results from the 
current study. Their athletic population of thirteen participants had a mean maximal VO2 
value of 33.7 ± 5.2 ml·kg·min-1 whereas the sedentary females with an SCI had values 
closer to those found in the present study, 18.3 ± 3.3 ml·kg·min-1. Many of the athletes 
included in the athletic group of the Schmid et al. study had lower limb amputations and 
six of them had a SCI between T11 and L5. As discussed in the previous section, the 
level of SCI has an inverse relationship with maximal oxygen consumption. This low 
level of SCI or lack of any injury to the spinal cord normally results in more active 
muscle tissue which can lead to higher maximal oxygen uptake capacity. 
Published research in the area of maximal testing with athletes with cerebral 
palsy (CP) is also very limited. Van der Woude et al. (2002) included 7 athletes with CP 
(6 male, 1 female). They reported average values of 154 ± 32 bpm for HRpeak, 0.80  ± 
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 0.44·min-1 for VO2peak and a mean RER value of 0.98 ± 0.12 during a test of maximal 
aerobic capacity. The participant in the current study with CP had comparable maximal 
values. 
 
4.1.2 Participants’ Body Composition  
The body composition data for wheelchair athletes is limited, and again, must be 
considered in the context of the individual nature and impact of the injury.  Jones, 
Goulding and Gerrard (1998) assessed body composition using DXA in five paraplegic 
males, at least 1 year post injury (1 to 30 years post injury), and compared the results to 
those of 10 age matched able-bodied controls. In addition to a 16% reduction in lean 
tissue mass and a 12% reduction in bone mass, individuals in the SCI group had a 47% 
greater body fat percentage. The pooled results for percent body fat, FFM, and BMC of 
participants in the current study were comparable to the results reported by Jones et al. 
(1998). Similarities within the participant sample were also noted for time since injury. 
In the current study the range was 0.5 years to 28 years. However, when the results are 
separated by gender, the males in the current study had lower % BF and more FFM 
compared to the five males in the Jones et al. study. This difference is perhaps due to 
fitness level, as the five males were not reported as being athletes and there was no 
information provided regarding the participants’ level of physical activity. Bulbulian, 
Johnson, Gruber and Darabos (1987) evaluated the body composition of twenty two 
male athletes with a SCI and compared them to 75 able-bodied controls. The percent 
body fat for the male athletes with a SCI were similar to the current study; they reported 
comparable values of 22.3 ± 8.8 % BF (Bulbulian et al., 1987).  
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 One study which had a sample of male and female athletes with an SCI reported 
% BF results from DXA of 25.1 ± 7 and mean BMI of 22.2 (Mojtahedi,Valentine, 
Arngrimsson, Wilund & Evan, 2008). Both values are lower than the body composition 
results from this study. It is important to note that the mean age from the Mojtahedi et al. 
(2008) study was 22.2 years, which may account for some of the differences. A 
limitation to their published results is that they did not separate their data by gender, 
which would provide more significance to their findings since published research with 
female data is very limited.  
Changes in body composition which occur post SCI may be time dependent 
(Wells & Hooker, 1990; Garland et al., 1992). Garland et al. (1992) noted that bone loss 
occurred to the greatest extent during the first 3 to 6 months after the injury. The bone 
mineral content stabilizes at approximately 66% of the original mass at 12 to 16 months 
post SCI (Garland et al., 1992). The participants with a SCI (n=7) in the current study 
were 15.6 ± 9.3 years post injury with a range of 0.5 to 28 years. One of the participants 
was only 6 months post injury at the time of the body composition exercise testing. 
Therefore his body composition data may have represented the initial changes that occur 
after injury. With his BMD value removed for analysis the mean value does not change: 
1.32 g·cm2 (n=6). The importance of the body composition data from the current study is 
not only for the characterization of the participants but also to contribute to the quantity 
of research in the area. With more research in this area new guidelines could perhaps be 
developed to look at body composition, specifically FFM, in related to resting energy 
and macronutrient requirements.  
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 4.2 Fuel Use During Exercise 
Fuel utilization during exercise is affected by intensity level, mode of exercise, 
fitness level and duration of exercise (Coggan, 1991). As exercise intensity rises, plasma 
glucose utilization increases due to an increase in muscle fibre recruitment in addition to 
an upsurge in glucose consumption by each active muscle fibre. In regards to mode of 
exercise, at the same relative intensity, the reliance on glucose is greater during exercise 
performed with a smaller muscle mass; for example arms versus legs (Ahlborg et al., 
1986). In the current study the deltoid, biceps and triceps were the main movers, placing 
an increased dependency on CHO as the fuel source. This is supported by the elevated 
RER values noted in both trials. An individual’s training status also plays a role in fuel 
utilization during exercise. As fitness level increases fat becomes a more dominant fuel 
source at higher intensities. This shift may be due to hormonal changes that occur in 
response to exercise in the trained individual versus the untrained (Coggan, 1991). The 
changes that occur are a decrease in glucagon and catecholamine concentration and an 
increase in insulin concentration which have a sparing effect on glycogen stores 
(Coggan, 1991). 
The goal of CHO feeding during exercise is to provide a steady flow of 
exogenous glucose into the blood with minimal gastrointestinal distress with the intent 
of delaying the onset of fatigue (Coyle, 2004). The total CHO content of the beverage in 
the current study was 64 g, provided in four dosages of 200 ml. In relation to total body 
weight the dosage provided 0.84 ± 0.2 g CHO·kg-1, exceeding the current ACSM, ADA, 
DC (2000) guidelines of 0.7 g CHO·kg-1·h-1.  Maintenance of blood glucose may be 
more crucial for wheelchair athletes with a SCI because following injury there is a 
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 reduction in type I muscle fibre and a shift to type IIb motor units in the paralysed limbs 
(Burnham, Martin, Stein, Bell, MacLean & Steadward, 1997). Type II muscle fibres 
have a higher capacity for glycogenolysis and glycolysis, while type I fibres have a 
greater capacity for fat oxidation (Holloszy, Kohrt, & Hansen, 1996).  
In 2004 Spendiff and Campbell compared the effect of two different feeding 
regimes on a 20 minute performance trial following 60 minutes of exercise at 65% 
VO2peak conducted on a roller system.One trial was two dosages of 324 ml and trial two 
was four dosages of 162 ml of a 7.6% CHO beverage. They did not find a significant 
performance difference between their two feeding regimes. They did however note an 
11% improvement in the total distance covered in 20 minutes with the more frequent 
CHO feeding protocol (Spendiff & Campbell, 2004). This trend for performance 
improvements led to the feeding regime used in the current study.  When providing the 
8% CHO beverage every 15 minutes we were able to maximize not only their CHO 
intake but also the total volume of fluid consumed. Our study implemented strict dietary 
control between trials, a controlled pre-exercise meal and a longer performance trial. 
These changes in methodology may have resulted in no difference in performance 
between the CHO and placebo beverages.  
The current hydration recommendation for able-bodied athletes during exercise 
is to consume between 150 to 350 ml of fluids every 15 to 20 minutes depending on 
individual tolerances (ADA, ACSM, DC, 2000). The feeding regime used in the current 
study for both trials provided the participants with the ideal hydration protocol. Total 
fluids consumed during the 60-minute exercise trial were 800 ml of either the 8% CHO 
beverage or the placebo provided every 15 minutes. Previous research conducted with 
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 wheelchair athletes had not provided this volume of fluid. Spendiff and Campbell (2004) 
provided a total of 648 ml during the 60-minute exercise.  
Prior to the exercise trial many of the participants were concerned about the 
volume of fluid to consume therefore a plan was in place in case they needed to stop the 
trial to void their bladder. None of the participants reported any negative symptoms of 
stomach discomfort or need to urinate when provided with this volume of fluid. It is 
encouraging to demonstrate that all of the participants, even those with impaired sweat 
function were able to tolerate this volume of fluid. The current study was able to 
demonstrate that the participants can follow the hydration guidelines in place for able-
bodied athletes. Performance would not likely have been limited by hydration.  
Although research with an able-bodied population has shown a performance 
benefit of fuel use during exercise (Below et al., 1995; McConell et al., 1996; Sugiura & 
Kobayashi, 1998), the results from the current study did not find any performance 
improvements (p=0.237). Although six of the eight participants covered more distance 
during the second performance trial versus the first trial, when tested for statistical 
significance the order effect did not achieve significance (p>0.05).  
 
4.3 Pre-Exercise Carbohydrate Feeding Regime 
A possible explanation for the lack in performance benefit when consuming the 8% 
CHO beverage could be due to the pre-exercise feeding protocol that was utilized. The rate of 
plasma glucose utilization during exercise can be influenced by an individual’s pre-exercise 
nutrient intake (Coggan, 1991). Pre-exercise CHO feeding results in a change in fuel oxidation, 
shifting from free fatty-acid oxidation to an increase in glucose oxidation (Burke et al., 1998). It 
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 is possible that the pre-exercise meal suggestions developed for each of the participants resulted 
in an adequate amount of fuel to complete the exercise and performance trial to the best of their 
physical ability based on their current training and fitness status. Ideal pre-exercise feeding, 
providing between 1 to 4 g CHO·kg-1 body weight, was encouraged for all participants prior to 
both exercise trials. Each participant reported that they followed the dietary instructions prior to 
the exercise and performance trials. The goals of pre-exercise food consumption are to continue 
to fuel muscle glycogen stores if they have not fully recovered from a previous exercise session, 
to restore liver glycogen stores, especially following an overnight fast, ensure adequate 
hydration, prevent hunger, avoid gastrointestinal distress, and include foods that the individual 
feels confident with (Burke & Deakin, 2000). The pre-exercise meal might also explain the 
negligible use of fat as a fuel source during the exercise and performance trials as demonstrated 
by the high RER values.  
Other studies have tried to identify whether performance gains observed with CHO 
ingestion during exercise are due to the pre-exercise meal or to the CHO beverage provided 
during the exercise trial. Chryssanthopoulos, Williams, Nowitz, Kotsiopoulou, & Vleck, (2002) 
studied the performance and metabolic response in nine male able-bodied athletes following the 
ingestion of a pre-exercise CHO meal plus either a CHO beverage or plain water during a run at 
70% VO2peak to exhaustion. The performance parameter that was assessed was the exercise time 
to exhaustion. Similar to the current study, the pre-exercise meal was consumed 3 hours prior to 
exercise and contained 2.5 g CHO· kg-1 body weight. For the trial with the CHO beverage 
during exercise, the beverage was a 6.9 % CHO beverage and was provided every 20 minutes at 
a dosage of 2 ml· kg-1 body weight, which is approximately 146 ml. The participants had a 
relatively high fitness level of 63.5 ± 2.3 ml· kg-1·min-1 VO2max, and maximal heart rate of 186 ± 
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 4 bpm. There were no significant differences in oxygen uptake, heart rate, blood lactate and 
RPE values; findings which are similar to the current study. There was a performance benefit 
noted between the groups, the CHO meal pre-exercise plus the CHO beverage during the trial 
resulted in an increased time to exhaustion. It is important to note that the RER values during 
the first collection period were also elevated (0.96 in the meal plus CHO beverage and 0.95 in 
the meal plus water trial) (Chryssanthopoulos, et al., 2002). The authors also noted that the pre-
exercise CHO meal led to the suppression of FFA mobilization and glycerol concentrations in 
the blood, producing a greater reliance on CHO as the dominant fuel source. Insulin levels were 
also elevated following the CHO meal pre-exercise, which has a direct impact on fatty acid 
utilization (Chryssanthopoulos, et al., 2002). An interesting point that was noted by 
Chryssanthopoulos, et al. (2002) was that the pre-exercise meal might have led to an additional 
energy source at the start of the exercise trial with undigested CHO still present in the 
gastrointestinal tract, which may also contribute some CHO for muscle metabolism.  
The most recent study published by Spendiff and Campbell (2005) assessed the impact 
of pre-exercise CHO feeding. They provided eight male athletes with an SCI with either a 4 % 
or 11 % CHO beverage 20 minutes prior to the exercise and performance trial. The beverage 
contained either 24 g or 72 g of dextrose monohydrate in a 600 ml solution. No additional CHO 
source or fluid was provided during the exercise and performance trial. The concentration of 
CHO provided pre-exercise did not affect the performance measures of power output or distance 
covered (Spendiff & Campbell, 2005). The CHO content of the pre-exercise beverage did 
however affect the free fatty acid (FFA) concentration. The 4% CHO beverage resulted in 
significantly higher levels at the completion of the 1 hour exercise trial. While the current study 
did not measure FFA concentration is was apparent during the exercise and performance trials 
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 that the dominant fuel source was glucose, as supported by the elevated RER values. The pre-
exercise CHO feeding regime used in the current study may have had a similar effect on fatty 
acid oxidation as indicated by RER values at the end of the performance trial. The RER values 
were significantly lower during the last 10 minutes (20-30 min) of the placebo trial versus the 
CHO beverage trial.  
 
4.4 Respiratory Exchange Ratio 
Respiratory exchange ratio was calculated during the exercise and performance 
trials as the ratio between the volume of CO2 released and the volume of O2 consumed. 
This method does have some limitations. It assumes that the body’s oxygen content 
remains constant and that the CO2 exchange at the lungs is proportional to its release 
from the cells (Wilmore, Costill, & Kenny, 2008). During the 60-minute exercise trial 
there was a significant interaction and post hoc tests revealed significantly higher RER 
values for the final 5 minutes of the 1 hour exercise component (p<0.05). From the first 
collection period during the 60-minute exercise trial the RER values were indicative of 
almost complete utilization of glucose, for both beverage trials. These data are in 
contrast to that of Spendiff and Campbell (2004) who reported lower RER values (0.91 
± 0.05) during exercise at 60 ± 3 % VO2peak, for first 20 minutes of the 4 x 162 ml 
feeding regime trial. Reasons for this difference could have been due to the pre-exercise 
feeding regimen as suggested by Chryssanthopoulos, et al. (2002), who reported RER 
values of 0.96 and 0.95 three hours after the pre-exercise meal in able-bodied male 
athletes. The current study provided instructions on the ideal pre-exercise meal, 
providing example food portions of high CHO choices. Spendiff and Campbell (2004) 
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 instructed consumption of the participant’s normal food intake and a three hour fast. 
They did not encourage any specific CHO content for the meal. It is well recognized that 
as more CHO is utilized RER values get closer to 1.0, indicating increased demands on 
blood glucose and muscle glycogen stores and increased carbohydrate oxidation 
(Wilmore, Costill, & Kenny, 2008).   
In the present study, RER values during the final 10 minutes of the performance 
trial (20-25 & 25-30 min) were significantly higher during the CHO beverage trial than 
the placebo trial. The RER results from the current study are in contrast to the findings 
of Spendiff and Campbell (2004). The RER results presented for the more frequent 
feeding regime were much lower during the performance trial. The average RER values 
for the performance trial were 0.94 ± 0.03 for the 4 x 162ml feeding regime (Spendiff & 
Campbell, 2004). With a comparison made between our CHO beverage trial and 
Spendiff and Campbell’s (2004) more frequent feeding regime, the RER values indicate 
that the methodology used in the current study resulted in a greater dependency on CHO 
as the dominant fuel source during the performance trial.  
In the present study the RER values for both trials were high beginning with the 
first collection period and remained elevated throughout the exercise and performance 
trial. When the RER values were assessed by injury level, similar trends were noted. For 
the three male participants classified as having paraplegia (T3, T4, L1), the RER 
response followed the same relative curve, with high values noted in both trials 
beginning with the first collection period. The CHO beverage trial resulted in RER 
values above 1.0 for the entire 30-minute performance trial. Values at the end of the 
performance trial for the CHO beverage and placebo trial were above 1.0, indicating that 
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 CHO was the dominant fuel source. With the two male participants with quadriplegia 
(C6, C5-6) the RER values were more erratic. The participant with SCI at C5-6 had 
higher RER values during the placebo trial. Values at the completion of the 30-min 
performance trial were 1.03 for the placebo trial and 0.99 for the CHO beverage trial. 
Reasons for this cannot be explained by relative exercise intensity as both trials were 
conducted at very similar percentages of VO2peak. Another individual who demonstrated 
very unique RER values was the participant with CP. His RER values were very erratic; 
the placebo trial resulted in higher RER values for most of the performance trial. The 
CHO beverage trial RER values were erratic and did not follow a similar pattern in 
comparison to the other participants. For the female participants (T12-L1, T1), the CHO 
beverage trial resulted in higher RER values for the 60-minute exercise and performance 
trial. This is important to note especially since both participants conducted the CHO 
beverage trial during the luteal phase of their menstrual cycles, which has been shown to 
result in lower RER values (Hackney, 1999). They completed the placebo trial during 
the follicular phase, in which the RER values were consistently lower.  
Determining the cause for such variability in RER values for each of these 
participants would be very challenging as no other published study has presented 
individual data. Speculations could be made regarding individual fitness level, level of 
injury, or active muscle mass involved in the exercise. As noted in the previous section, 
the pre-exercise feeding regime might have also played an important role. Having a 
relatively high CHO meal three hours prior to both exercise and performance trials may 
have lead to minimal fat oxidation. The findings for the paraplegic participants from this 
study are supported by previous research with an SCI population that has shown 
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 elevated RER values during exercise (Astorino & Harness, 2009; Knechtle et al., 2004). 
Obviously many unique factors are involved in fuel metabolism during exercise. 
Campbell, Williams, & Lakomy (2004) reported a significant decrease in RER   
during a 90 minute exercise trial without a CHO fuel source. Twenty athletes with a 
variety of spinal cord injuries participated in their research study. The RER values 
decreased significantly as the exercise test progressed (p<0.05).  Respiratory exchange 
ratio of 0.91 for the T3 athletes and 0.92 for the T4 athletes were noted at the start of the 
exercise and dropped to 0.82 for the T3 athletes and 0.80 for the T4 athletes at the 
completion of the 90-minute exercise (Campbell, Williams, & Lakomy, 2004). The 
decrease in RER as the exercise regime progressed indicates a switch to lipid 
metabolism. Values seen with able-bodied individuals at rest are usually in the range of 
0.78 to 0.80 (Wilmore, et al., 2008). As noted in the current study, the average RER 
values during the first collection period (0-5 min) were 0.99 ± 0.04 for both the placebo 
trial and CHO beverage trial, indicating very limited use of fat as a fuel source.  
Throughout the placebo trial the RER values dropped by a small amount. 
However individual calculations of fat oxidation still revealed negative values, 
suggesting negligible fat oxidation. The cause for this dependence on carbohydrate as 
the primary fuel source even at moderate intensities of 57 % VO2peak may be due to the 
pre-exercise meal being high in total grams of CHO in conjunction with the arm specific 
mode of activity.  
Providing instructions on ideal pre-exercise feeding may have resulted in an 
increase in glucose availability during both exercise trials. Pre-exercise CHO feeding 
has been shown to increase insulin levels, decrease glucagon levels which may suppress 
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 fat metabolism and maintain higher rates of CHO oxidation later into the exercise trial 
(Coyle, 1999). The transport of fatty acids through the mitochondrial membrane can 
limit fat oxidation during exercise and this process is sensitive to CHO metabolism, 
indicating that during exercise fat oxidation in the skeletal muscle is largely regulated by 
CHO metabolism. Conditions which have shown a shift away from fat oxidation are pre-
exercise CHO intake and increased exercise intensity. There seems to be a preference for 
CHO when both CHO and fat are available to the muscle and this may be mediated by 
active inhibition of fat oxidation through a process that involves the transport of fatty 
acids into the mitochondria. Sidossis (1998) found that glucose directly determines the 
rate of fat oxidation by controlling fatty acid transport into the mitochondria even at 
moderate intensities of 30 to 65 % VO2max. At intensities above 65 % VO2max the relative 
contribution of glucose from plasma and the breakdown of muscle glycogen increase 
and total fat contribution decreases (Sidossis, 1998). Therefore an ideal CHO pre-
exercise meal actively and directly inhibits the oxidation of fatty acids at the skeletal 
muscle.  The participant’s ability to oxidize fatty acids even at moderate intensities (57 
% VO2peak) might have been limited by their level of fitness, especially their endurance 
fitness. Many of the participants were from team sports which would not necessarily 
mean that they train their aerobic system to the same extent as endurance athletes. 
Untrained able-body athletes have lower fat oxidation rates during moderate intensity 
endurance training versus endurance-trained athletes (Coyle, 1999).  
Another explanation for the complete dependency on CHO as the dominant fuel 
source during exercise for both trials may be due to the mode of exercise. Ahlborg, 
Wahren and Felig (1986) studied the metabolic impact of either leg or arm exercise with 
72 
 
 able-bodied participants. Their study included twelve male participants, six of who 
performed the arm exercise trial while the other half completed the leg trial. The 
exercise trial was two hours in length at low intensity of 30 % VO2peak. The arm exercise 
trial led to a 25 to 40 % increase in heart rate, increased arterial concentrations of lactate, 
catecholamines, FFA and a significant increase in RER values. Arm exercise resulted in 
a greater utilization of glucose by the exercising muscle tissue as well as an increase in 
hepatic gluconeogenesis from lactate and glycerol. The authors proposed that the 
difference in fuel utilization between the leg and arm exercise was due to increased 
glucose oxidation increased in arm exercise due to smaller muscle mass activation 
(Ahlborg et al., 1986). Therefore a greater intensity of work done by the individual 
muscle groups was required to maintain the same intensity. They also noted the 
differences in muscle fibre composition and enzyme activity in the arm muscles versus 
the legs (Ahlborg et al., 1986). Due to normal daily activity, the leg muscles have a 
greater content of oxidative enzymes. Obviously a major difference between the able-
bodied participants in the Ahlborg et al. (1986) study and the current research is that 
individuals with a SCI might adapt and become more efficient with arm exercise.  
 
4.5 Carbohydrate Oxidation During Exercise 
Carbohydrate oxidation was calculated using the equations of Jeukendrup & 
Wallis, (2005), which considers protein oxidation as negligible. This assumption is 
appropriate for the current study since protein is normally only oxidized when 
individuals are exercising in a fasted state, performing prolonged exercise or are under 
metabolic stress (Rodgers, 1998). In a study conducted by Campbell et al. (2004), they 
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 did note that amino acid oxidation may have occurred during the 90-minute exercise 
trial. Their results indicated that both ammonia and urea concentrations were elevated 
for all paraplegic racing classes at the end of the exercise. The difference in 
methodology may explain why the current study is making the assumption of negligible 
protein oxidation. Campbell et al. instructed the participants to arrive in a fasted state 
and did not provide instructions regarding their pre-exercise feeding regime. The current 
study provided detailed instructions to ensure that the CHO content of the meal would 
be optimal. For both exercise trials the participants were not in a fasted state as they had 
been instructed to consume a pre-exercise meal 3 hours prior to the trial.  
During the 60-minute exercise trial there was no significant main effect of time 
for CHO oxidation (p=0.087). For the 30-minute performance trial a significant 
interaction was noted. Post hoc analysis revealed that the CHO beverage resulted in 
higher CHO oxidation rates during the final 5 minutes of the performance trial. These 
findings are consistent with our primary hypothesis that the 8 % CHO beverage trial 
would result in higher oxidation of CHO versus the placebo beverage trial. Although 
provision of the CHO beverage resulted in an increased rate of oxidation this factor did 
not impact the participant’s performance or rating of perceived exertion. Performance 
may have been improved if the participants were to have completed the exercise trial in 
a fasted state as discussed in the previous sections, placing a greater dependency on 
exogenous CHO sources. Limited information is available on CHO oxidation during 
exercise for athletes with a physical disability. Previous published research with this 
population has not provided detailed information on CHO oxidation values for 
comparison.  
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 4.6 Impact of CHO Feeding on Blood Glucose Values 
The goal of CHO feeding during exercise is to provide a steady flow of 
exogenous glucose into the blood with minimal gastrointestinal distress (Coyle, 2004). 
During the CHO beverage trial there were no anecdotal reports of gastrointestinal upset 
or intolerances of the volume of fluid provided. For the blood glucose results there was a 
significant beverage by time interaction, with each beverage affecting the blood glucose 
values differently over time. The 8 % CHO beverage trial resulted in higher blood 
glucose values during the 60-minute exercise trial and at the completion of the 30-
minute performance trial compared to the placebo beverage trial. Similar results were 
reported by Spendiff and Campbell (2004) who demonstrated that the more frequent 
feeding regime, 4 x 162 ml of 7.6 % CHO beverage resulted in more steady blood 
glucose levels versus the 2 x 324 ml regime. The individual blood glucose responses to 
both trials can be found in Appendix IX. A similar trend in blood glucose values was 
found for five of the male participants (C6, C5-6, T3, T4, L1). For all five, the CHO 
beverage trial resulted in higher blood glucose values during the exercise, performance 
trial and into the recovery period. The same pattern was not shown however with the 
two female participants (T12-L1, T1). Their blood glucose responses were observed to 
be higher during the CHO beverage trial for the 40-min, 60-min and post collection 
periods, but during the recovery phase the placebo trial resulted in higher values. A 
similar response was noted with the participant with CP. Reasons for this variability in 
blood glucose response is not known. It may have been caused by the breakdown of 
amino acids via gluconeogenesis in order to supply adequate glucose for the muscle and 
nervous systems. Both of the female participants conducted the placebo trial during the 
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 follicular phase of their menstrual cycles, but previous research has shown that CHO 
consumption during exercise at varying times during the menstrual cycle does not 
impact blood glucose response (Bailey et al., 2000).  
The results from our study demonstrate that even though blood glucose was 
maintained with the 8 % CHO beverage, it was not enough to lead to a performance 
gain. The performance benefit of the enhanced levels of glucose may have been noted if 
the participants continued to exercise for a longer period of time, placing a greater 
emphasis on exogenous CHO. Carbohydrate consumption during exercise over 2 hours 
has been shown to delay the onset of fatigue and prevent the development of 
hypoglycaemia due in part to the sparing of liver glycogen stores (Coyle, 2004).  
Since this study is the first to date to conduct a 30-minute performance trial 
immediately after the 60-minute exercise trial, it was a concern that some of the 
participants would not be able to complete the full performance trial. Only one 
participant was not able to complete the full trial (completed 22:33.00 of the 30-minute 
performance trial). Therefore for the second exercise and performance trial their time 
was limited to 22:33.00 so that comparisons could be made between trials based on total 
distance covered. One anecdotal report from a participant was that at the completion of 
the 30-minute performance trial with the placebo beverage they experienced full body 
fatigue, more so than during the CHO beverage trial. Since blood glucose levels were 
more stable during the CHO beverage trial, this help to explain the different in full body 
fatigue. One of the major benefits to CHO feeding during exercise is that maintaining 
blood glucose levels encourages ongoing training leading to enhanced endurance 
capacity. The participants would not be forced to stop exercising due to the depletion of 
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 muscle glycogen stores or the development of hypoglycaemia (Holloszy, Kohrt, & 
Hansen, 1996). The overall health benefits of improved endurance capacity, fitness and 
perhaps a change in body composition would definitely lead to the recommendation of 
CHO consumption during prolonged training sessions.  
 
4.7 Impact of Gender on Fuel Utilization 
Numerous studies have demonstrated that women have a lower RER during 
exercise when compared to men, indicating a greater reliance on fat oxidation (Devries 
et al., 2006; Braun et al., 2005). The reduced oxidation of CHO during exercise could be 
due to a decreased utilization of muscle glycogen, lower utilization of blood glucose or 
both (Horton et al., 2006). Since previous research has found that the hormonal 
fluctuations that occur during the menstrual cycle may impact glycogen utilization 
during exercise, both female participants were asked about their menstrual cycle 
schedule in relation to the testing dates. Hackney (1999) found that muscle glycogen 
utilization was lower during the luteal phase when oestrogen was the highest and that a 
significant negative relationship existed between the oestrogen levels and the amount of 
glycogen utilization. They noted that RER values were significantly lower during the 
luteal phase versus the follicular phase, suggesting enhanced lipid utilization during 
exercise (Hackney, 1999). Under conditions similar to the current study, Bailey et al. 
(2000) studied the impact of a CHO beverage consumed during exercise to see if 
providing a fuel source during exercise would negate the impact of the menstrual cycle 
on fuel utilization. Their research design involved four exercise trials, two during the 
luteal phase and two during the follicular phase. During both phases the nine female 
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 participants were provided with either a 6 % CHO beverage or placebo. The participants 
were told to cycle to exhaustion. Their results indicated that the time to exhaustion was 
increased with the CHO beverage, but there was no difference between the luteal and 
follicular phase. There was also no difference between phases for FFA, plasma glucose 
or insulin levels. Although our study did not find the performance gains, one similarity 
is that Bailey et al. (2000) did not find an impact of the 6 % CHO beverage on the 
participants’ RPE values. For the two female participants included in this study, 
menstrual cycle was documented but was not controlled.  
Due to three female participants not completing all aspects of the research study, 
both females that did complete the exercise trials received the CHO beverage during the 
first exercise trial and the placebo beverage during the second trial. Participant 3 
conducted her first exercise trial with the CHO beverage on day 28 of her menstrual 
cycle and her second trial with the placebo beverage on day 7 of her menstrual cycle. 
Participant 8 conducted her first exercise trial with the CHO beverage on day 25 of her 
menstrual cycle and her second exercise trial with the placebo beverage on day 4 of her 
menstrual cycle. For both female participants the CHO beverage did not enhance 
performance. 
 
4.8 Impact of CHO Feeding on Blood Lactate Values  
There was a significant main effect of time (p>0.05) for lactate, indicating that 
when the pooled means from both the CHO trial and placebo trial were combined there 
was a significant difference across time points. The blood lactate values increased over 
time as expected. There was no effect of the CHO beverage on the lactate values during 
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 the 60-minute exercise trial or any of the post-performance values (p=0.082). The lactate 
values for the three males with paraplegia were quite erratic in pattern. All three had 
elevated values for both the CHO beverage and placebo post-performance trial. During 
the recovery phase each participant’s values followed a similar decreasing pattern. For 
the two female participants, the lactate responses were quite unique. Both had elevated 
values after the performance trial, but the spikes in values were different between the 
two trials. The participant with an SCI at T1 had a spike in blood lactate values at 2-min 
post during the placebo trial (19.7 mmol.l-1) and a spike at 5-min post with the CHO 
beverage trial (15.4 mmol.l-1). The increase in blood lactate during the placebo trial does 
correspond with an increase in blood glucose values at 2-min post performance trial. 
Deschenes, Hillard, Wilson, Dubina, and Eason (2006) noted that blood lactate post 
exercise and during the recovery phase (5-min and 15-min post) is higher in male 
participants versus females. This pattern was not evident in the current study. For the 
two males with quadriplegia the blood lactate values followed a similar pattern. The 
values were higher post exercise and into the recovery period during the CHO beverage 
trial. The participant with CP had a different blood lactate response. The values spiked at 
2-min post but the placebo trial resulted in higher values. The lactate values at 2-min 
post followed the same pattern as the blood glucose response during the placebo trial. 
For all of the participants the blood lactate values at the end of the recovery period (10-
min post) were still elevated, which could be a reflection of their fitness level and the 
muscle fibre type involved in the exercise. Blood lactate would accumulate, even during 
moderate intensity exercise, due to active muscle mass not having the oxidative capacity 
to oxidize lactate. Therefore accumulation would exceed removal rate. 
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 When comparing the group mean values from the current study, research 
conducted with able-bodied participants has shown similar results for blood lactate 
values during exercise. Dumke, McBride, Niemen, Gowin, Utter and McAnulty (2007), 
found that providing either a 6 % CHO beverage or placebo during a 2.5 hour cycling 
protocol did not impact blood lactate levels. Murray et al. (1989) studied the effect of 
ingesting fluids of varying CHO content during a 1.25 hour intermittent cycling trial in a 
warm environment. Both male and female participants were recruited and 12 completed 
the study. The exercise trials were also conducted at 65 % VO2peak, and each participant 
completed the trials on four separate occasions. The treatment beverages were a water 
placebo, 6 % sucrose, 8 % sucrose, and 10 % sucrose. With all four trials blood lactate 
values increased significantly over time but there was no difference between treatment 
trials (Murray et al., 1989). The CHO beverages resulted in higher blood glucose values 
and RER values during the final 20 minutes of the performance trial, which is similar to 
the findings of the current research study. 
 
4.9 Oxygen Uptake and Heart Rate Values 
Analysis of the physiological response to the 60 minute exercise trial indicated 
that the participants were exercising at 57.4 ± 6.8 % VO2peak and 57.1 ± 6.5 % VO2peak 
during the CHO beverage trial and placebo trials respectively. For the 30-minute 
performance trial, there was no significant difference in the percent VO2peak values. 
There was a significant effect of time for both the 60-minute exercise trial and 30-
minute performance trial for VO2 (l·min-1) although there was no significant difference 
between beverage trials. The increase in VO2 was expected as previous research 
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 conducted with wheelchair athletes has shown similar results (Spendiff & Campbell, 
2004, 2005). Heart rate did not change over time during the 60-minute exercise trial, 
indicating that the participants were able to maintain a steady state of exercise intensity 
over the 60 minutes prior to the start of the performance trial. As expected, heart rate 
increased during the performance trial (p=0.009). Heart rate during the performance trial 
was not affected by the nature (CHO or placebo) of the beverage consumed (p>0.05). 
Spendiff and Campbell (2004) found that VO2 (l·min-1) and heart rate increased during 
the exercise and performance trials but there was no significant main effect of the 
beverage feeding regime, which is consistent with the current study.  
 
4.10 Rating of Perceived Exertion  
Research with able-bodied athletes has shown that RPE is significantly lower following 
the ingestion of CHO during exercise compared to a placebo beverage (Backhouse et al., 2005). 
Utter et al. (2007) studied the impact of CHO feeding during intermittent exercise on RPE with 
12 male cyclists. The exercise trial included 2 hours at 73 % VO2peak with 3-minute rest 
intervals every 10 minutes. The participants were provided with a 6 % CHO beverage or 
placebo beverage pre-exercise and during the trial. During the last minute of each 10-minute 
bout of exercise the participants rated their overall body RPE. The RPE patterns were 
significantly different between the CHO and placebo trials. The data indicated that CHO 
supplementation during intermittent exercise attenuated perceived exertion (Utter et al., 2007). 
Our results are not consistent with these findings.  
There have been some published research studies that support our findings. Brisswalter, 
et al. (2000) examined the effect of a 5.5 % CHO or placebo beverage on the energy cost of 
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 running in ten male triathletes. Providing either the 5.5 % CHO beverage or placebo in 140 ml 
dosages every 20 minutes during the 2-hour running trial did not affect the energy cost of 
running or the RPE. The RPE increased over time but did not differ between trials, similar to the 
present study. One comparison that cannot be made is whether or not a pre-exercise meal led to 
this lack of difference in RPE between trials, as Brisswalter et al. (2000) did not comment on 
the pre-exercise meal. In the present study the pre-exercise meal was controlled and this meal 
may have provided the participants with adequate fuel to complete the exercise and performance 
trial on both occasions to the best of their ability with no significant impact on their perception 
of work effort or fatigue.  
It is of note that one participant did respond differently to the two beverages and 
reported the feeling of overheating during the placebo trial at minute 12 into the 30-minute 
performance trial. The participant’s body temperature was not measured during the exercise 
trials, but it was apparent that this participant had to decrease their intensity during the 
performance trial due to their discomfort. Future research should also monitor body temperature 
during exercise to identify if nutrient or electrolyte beverage composition affects temperature 
regulation in individuals with impaired sweating.  
 
 
4.11 The Participants’ Dietary Intake Patterns 
 In order to make individual dietary recommendations, information on total energy 
requirements is necessary. The published data regarding energy needs of individuals 
with varying levels of ability includes participants with amputations, varying levels of 
paralysis, spinal cord injuries, and cerebral palsy. To state that this information can be 
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 applied specifically to athletes with paraplegia or quadriplegia would not be appropriate. 
Research has been conducted with sedentary individuals with SCI in order to determine 
the effect of the level of injury on resting energy needs and thermic effect of food (TEF). 
Monroe et al. (1998) studied 10 male participants with varying levels of spinal cord 
injuries. The participants were classified as sedentary to moderately active; therefore 
they were not an athletic population. There was a significant reduction in daily energy 
expenditure in the SCI participants versus the able-bodied controls. After adjustments 
were made to account for the lower FFM values in the SCI group, the 24 hour energy 
expenditure was on average 180 kcal·d-1 lower in this group compared to the able-body 
controls (p<0.01). They reported 24-hour energy requirements of 1,869 ± 73 kcal·d-1 for 
the ten male SCI participants. A difference was found between the two groups for 
spontaneous physical activity, with the SCI group reporting lower energy values. They 
also found a significant difference between groups for the TEF. Thermic effect of food 
accounted for 12.1 % of total energy intake for the SCI participants and 15.3 % for the 
able-bodied controls. Abel et al. (2003) measured resting energy requirements for 27 
athletes with a variety of physical abilities (SCI, spina bifida, amputations, post-polio 
syndrome), and found mean basal metabolic rates to be  65.4 ± 14.1 kcal·hr-1 for the 
hand bike athletes and 60.3 ± 9.1 kcal·hr-1 for the wheelchair racing athletes. These 
values would result in resting daily requirements of 1,488 to 1,560 kcal·d-1 plus 
additional energy needs for physical activity. Comparing these values to our current 
population would indicate that energy needs are being met, with 2,438 ± 528 kcal·d-1, 
but since each participant has a unique level of physical ability making these types of 
comparisons might not be appropriate.  
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  Level of injury will determine the muscle groups being used on a daily basis which 
will impact energy needs, but the energy cost of daily living (transfers, mobility, etc.) 
will be much greater than non-SCI individuals (Cox et al., 1985). Cox et al. studied the 
energy requirements of 22 sedentary individuals with a SCI that were currently 
undergoing rehabilitation in a hospital setting using indirect calorimetry.  The results 
indicated that the individuals with quadriplegia needed 22.7 kcal·kg·d-1 and individuals 
with paraplegia required 27.9 kcal·kg·d-1. Dietary estimates made from a 24-hour recall 
indicated that energy intake was exceeding caloric requirements with individuals 
consuming approximately 1,774 kcal·d-1 (27.4 kcal·kg-1·d-1). The dietary estimates were 
also supported by the fact that the participants were gaining weight, indicating that a 
positive energy balance was being achieved. Detailed information regarding the dietary 
composition was not provided. The mean energy intake from the current study was 31.6 
± 7.1 kcal·kg-1·d-1, which exceeded the values reported by Cox et al. (1985). Making a 
comparison to the findings by Cox et al. may not be appropriate however since their 
population was sedentary; therefore increased activity levels could account for the 
increased energy needs of the participants in the current study. Information regarding 
trends in body weight was not collected, therefore it is not known if the participants 
were exceeding their energy needs. Only two of the participants in the present study 
were below the caloric needs identified by Cox et al.  
 Published data describing the dietary patterns of wheelchair athletes is, to the best 
of our knowledge, unavailable. Nutritional information was collected using a modified 
3-day food record. The food records were used primarily to control for dietary intake 
between the two exercise and performance trials. Since the existing nutritional literature 
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 is lacking specific energy and macronutrient recommendations for wheelchair athletes, 
able-bodied guidelines for athletes and active adults were utilized for comparison. The 
current ADA, ACSM and DC (2000) recommendations were viewed as the top end of 
the range for energy and macronutrient intake. The low end of the range was the 
acceptable macronutrient distribution range (AMDR) values and the RDA and AI values 
(IOM, 2005). The AMDR values are a percentage of total calories consumed (% kcal). 
The AMDR values are 45 to 65% kcal for CHO, 10 to 35% kcal for protein and 20 to 
35% kcal for fat (IOM, 2005). It has been stated that “any macronutrient needs of an 
athlete should also fit within these AMDR ranges” (Zello, 2006, p.75). Only 25% of the 
participants met the daily caloric recommendations for active adults (active = 37 to 41 
kcal·kg-1·d-1; SCI = 31.59 ± 7.10 kcal·kg-1·d-1). An important consideration with 
estimates of energy requirements is that the values are only estimates. In regards to 
energy intake, the participants were not asked about their body weight history. This 
information could have been used to assess if energy intake patterns are maintaining 
body weight, causing a gain in weight or a loss. Knowing their body weight history 
would have provided additional information concerning whether they were achieving an 
energy balance. 
 Carbohydrate recommendations of 6 to 10 g·kg-1 body weight·d-1 were not met by 
any of the wheelchair athletes. This recommendation is to maintain blood glucose levels 
during exercise and to replace muscle glycogen stores (ADA, ACSM, & DC, 2000). The 
mean intake of CHO was 4.02 ± 0.75 g·kg-1 body weight·d-1. Seven of the eight 
participants were within AMDR and were all meeting the RDA for CHO (130 g·d-1). 
Since the participants in this study have less active muscle mass in comparison to able-
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 bodied athlete and active adult guidelines may not be suitable. Therefore the participants 
may have been consuming enough CHO on a daily basis to result in adequate muscle 
glycogen stores. This is supported by the blood glucose and RER values found in both 
exercise and performance trials. The impact on RER values could have resulted from the 
pre-exercise meal alone or from the dietary habits leading into the exercise trials. This 
complete dependency is not normally seen when participants consume a low CHO diet, 
RER indicates a higher utilization of FFA when muscle glycogen levels are low 
(Coggan, 1991).  
 Dietary protein needs are dependent on the type of sport involvement.  It is 
recommended that strength athletes consume 1.6 to 1.7 g·kg-1 body weight·d-1, and 
endurance athletes 1.2 to 1.4 g·kg-1 body weight·d-1 (ADA, ACSM, DC, 2000; Burke & 
Deakin, 2000). The participants from the current study were involved in neither strength 
nor endurance specific events. When compared to the overall recommendation of 1.2 to 
1.7 g·kg-1 body weight·d-1 63% of the participants were meeting this recommendation. 
In comparison to the RDA value for protein (0.8 g·kg-1 body weight·d-1) only one 
participant was below the recommendation. All of the participants were within the 
AMDR for this macronutrient. Average caloric intake from fat was 31 ± 5.8 % which 
exceeded current recommendation of 20-25 % total energy for the athletic population 
(ADA, ACSM, DC, 2000). In relation to the AMDR, two of the participants were above 
the range (>35% total kcal).When total fat intake exceeds the AMDR; total CHO for 
optimal muscle glycogen levels may be compromised. When a high fat diet is consumed 
on a daily basis it may limit an athlete’s ability to train effectively (Helge, 2000).  
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  Total daily fluid intake was below gender specific adequate intake values of 2,700 
ml for females and 3,700 ml for males. The mean value for total fluid intake was 2403 ± 
650 ml·d-1 (IOM, 2004). Since the AI for fluid also includes fluid sources from food the 
actual fluid intake would be slightly higher. Fluid from food usually accounts for 20 % 
of fluid intake and 80 % comes from liquids consumed. The AI for fluid also indicates 
that active individuals may require more fluid on a daily basis.  
 
4.12 Research Limitations 
 Sample size is an important limitation of this study. Power calculations had been 
completed prior to the start of data collection, and it was determined that 15 participants 
would be needed in order to achieve statistical power. The initial recruitment met the 
sample size requirement, but due to scheduling issues, injuries not related to the study 
and travel complications, only eight participants completed the full research study.  
More participants may have provided more insight into the impact of the CHO ingestion 
on fuel utilization and RPE. Other limitations with this study were the broad range of 
SCI and physical abilities (CP). These factors may have contributed to the large 
variability observed in many of the dependent variables measured.  
The differing electrolyte content of the two beverages may also have been a 
limiting factor as this may have impacted hydration status during exercise. The 
electrolyte composition for the 800 ml of 8% CHO beverage was 448 mg sodium, and 
139 mg potassium (Orange, Gatorade, Pepsico, Inc.). The placebo beverage contained 
160 mg sodium and 48 mg potassium per 800 ml (Orange, Nestea Acitv, Splenda© 
brand). The main focus with the beverage composition was to find a placebo control 
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 beverage that tasted similar to the CHO beverage. Since many of the participants have 
used Gatorade products before, we needed the placebo to be similar in taste and color. 
The placebo beverage was a great match for both taste and color but it did contain 
electrolytes.  
The limitations with using food records to determine an individual’s dietary 
intake include: underreporting, measurement effect, and error associated with portion 
size estimation (Block & Hartman, 1989). While efforts had been put in place to 
minimize these limitations, they must still be recognized. More space was provided for 
the meals and snack recording and individual instructions were provided to each 
participant by a registered dietitian detailing how to correctly complete the food records. 
Even with the adjustments and education provided, under or over reporting could have 
occurred.  Underreporting is the main limitation with self reporting food records. 
Therefore the actual dietary intake of the participants may have been higher than the 
results stated in this study. This would have had an impact on the 3-day food record 
results posted in addition to the energy available for each exercise trial in the form of 
muscle glycogen. Since muscle glycogen was not measured, the 3-day food record was 
the control for stored fuel sources leading into each trial. A large variation in CHO food 
intake would have resulted in different muscle glycogen stores and therefore varying the 
starting endogenous CHO stores. There was no measure of compliance incorporated in 
this study such as laboratory measures to assess macronutrient intake or hydration status.  
Another possible research limitation is the order effect. When the statistical 
analysis was conducted the order effect was not significant (p=0.096). Six of the 
participants performed better during the second exercise and performance trial, 
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 independent of the beverage provided. Only two participants covered a greater distance 
during the first exercise and performance trial versus the second trial. Both of these 
participants had the placebo during the first exercise and performance trial. 
Methodology used in this study had tried to avoid the possible order effect by 
conducting the VO2peak testing on the same exercise equipment in order to act as a 
familiarization trial. Perhaps a full exercise and performance trial held for the full 90 
minutes would have decreased the effect of order on performance measures. 
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 CHAPTER 5 
5. SUMMARY & CONCLUSIONS 
 
5.1 Summary 
This study investigated the effect of ingesting an 8 % carbohydrate beverage 
during a moderate intensity exercise bout followed immediately by a 30-minute 
performance trial on performance outcomes, fuel utilization and blood glucose levels of 
wheelchair athletes. Under random, double blind conditions seven athletes with a SCI 
and one athlete with CP completed two exercise and performance trials. During the 60-
minute exercise trial the participants were given four 200 ml dosages of an 8 % CHO 
beverage or a taste-matched placebo beverage. It was hypothesized that consumption of 
the CHO beverage would result in improved performance, maintain blood glucose 
values and lower ratings of perceived exertion.  The secondary purpose was to analyse 
the dietary intake of the eight participants and determine if they were meeting the sport 
nutrition guidelines for able-bodied athletes and active adults according to the American 
Dietetic Association (ADA), American College of Sports Medicine (ACSM) and 
Dietitians of Canada (DC) joint position paper.  
The results of the study failed to demonstrate any significant difference between 
beverages for total distance (km), average speed (km·h-1) or maximum speed achieved 
(km·h-1) during the performance trial. Only two of the eight participants covered more 
distance during the CHO beverage trial versus the placebo trial. Consumption of the 
CHO beverage did however result in higher blood glucose levels and greater CHO 
oxidation rates versus the placebo beverage. The CHO beverage also resulted in higher 
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 RER values during the exercise and performance trial. The ratings of perceived exertion 
were not affected by consumption of the CHO beverage. When comparing the 
participant’s dietary intakes to the current able-bodied athlete’s recommendations, they 
were not consuming enough total calories, total CHO and were exceeding the range for 
fat intake. The results from the 3-day foods records indicated that the participants were 
not meeting the current dietary recommendations for able-bodied athletes.  Only 25 % of 
the participants met the daily caloric requirements for able-bodied athletes. 
Carbohydrate requirements of 6 to 10 g·kg-1 body weight·d-1 were not met by any of the 
participants. Only 63 % of the participants were meeting the protein guidelines for able-
bodies athletes. Average caloric intake from fat exceeded current recommendations of 
20 to 25 % total energy for the athletic population. In comparison with the lower end of 
the range for macronutrient, seven of the eight participants were meeting the AMDR for 
CHO, all were within the AMDR for protein and two were exceeding the AMDR for fat. 
5.2 Conclusions 
Providing wheelchair athletes with an 8 % CHO beverage during a moderated 
intensity exercise trial did not improve distance performance during a 30-minute 
performance trial. The CHO beverage did elicit higher blood glucose levels, RER values 
and increased the rate of CHO oxidation but it did not alter the participants’ ratings of 
perceived exertion. The research protocol utilized may have negated the impact of the 
CHO beverage consumed during exercise. Three hours prior to both trials, each 
participant was instructed to consume a meal which provided them with 2 g CHO·kg-1 
bodyweight. While these instructions are in line with the current pre-exercise guidelines 
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 for able-bodied athletes this pre-exercise CHO meal may have provided them with 
enough fuel to complete the exercise and performance trial to the best of their physical 
ability. Therefore with the pre-exercise CHO meal consumed there were no performance 
benefits to consuming an 8% CHO beverage during the exercise trial. 
5.3 Recommendations for Future Research 
 Ongoing research is needed with wheelchair athletes with varying levels of functional 
muscle mass in order to develop specific sports nutrition guidelines for optimal performance. 
With increasing numbers of athletes with SCI or with CP competing in elite level sport, more 
published information is needed in regards to their dietary patterns. Using a 7-day weighed food 
records with a large sample of athletes would provide such in depth data. The dietary 
information could then be compared to physical performance and different dietary manipulation 
studies could take place. Assessing whether CHO loading strategies work with this specific 
population would also be very beneficial for endurance athletes. A critical component to 
determining dietary requirements would be to understand the resting energy requirements and 
energy needs of daily living of wheelchair athletes. Determining daily energy requirements with 
the use of doubly labelled water research would provide valuable information for dietitians 
working in the field of sports nutrition. Dietitians working with specific athletes and teams 
would be able to develop individual meal plans for optimal performance. In order to identify the 
main effect of CHO consumption during exercise future research should implement an exercise 
protocol that begins with the participants in a fasted state. This would eliminate the impact of 
the CHO energy source at the start of the exercise trial. Having the participants start the exercise 
in a fasted state would place a greater importance on exogenous glucose since the liver glycogen 
stores would be lower. This research strategy would perhaps isolate the performance impact of 
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 CHO feeding for wheelchair athletes during exercise. Another approach would be to study the 
gastric emptying rate in athletes with an SCI to identify if the CHO consumed pre-exercise is 
still present in the gastrointestinal tract during the early phase of exercise, therefore providing 
an additional fuel source.  
Future research should also monitor body temperature during exercise in order to identify 
if nutrient or electrolyte beverage composition affects temperature regulation in individuals with 
impaired sweating abilities. Since each participant in the current study had a unique level of 
injury, future research should focus on grouping the participants by injury in order to develop 
guidelines based on specific spinal cord injury levels. With the limited information that is 
known in regards to fuel metabolism during exercise, more research is needed to identify the 
impact of exercise intensity on fat oxidation, CHO oxidation, in addition to other blood 
parameters.   
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INTRODUCTION 
You are invited to take part in this research study because we want to determine the 
effect of carbohydrate feeding during moderate intensity exercise on fuel use and 
performance measures. Before you decide to participate, it is important for you to 
understand what the research involves. This consent form will tell you about the study, 
why the research is being done, what will happen to you during the study and the 
possible benefits, risks and discomforts. 
Background information- Fuel utilization has been researched for several decades 
resulting in specific carbohydrate (CHO) ingestion guidelines for able bodied athletes 
involved in endurance and intermittent events. Research in the area of fuel metabolism 
during aerobic exercise by wheelchair athletes is relatively new. Athletes with a spinal 
cord injury (SCI) have a loss or impairment of both the sympathetic and parasympathetic 
response. This altered response may impact the action of major organs and hormones 
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 that play a direct role in substrate metabolism and cardiovascular response to exercise. 
Encouraging athletes with a SCI to follow the CHO guidelines developed for able body 
athletes may not be appropriate. To date only three research studies have been published 
on CHO requirements and exercise in athletes with a SCI, the studies were unable to 
determine an ideal feeding regime for optimal performance. The proposed study will 
determine the effects of an 8% CHO beverage during a moderate intensity exercise trial 
on the performance outcomes, fuel utilization and blood glucose levels of athletes with a 
SCI. 
 
If you wish to participate, you will be asked to sign this consent form. Your participation 
is entirely voluntary, so it is up to you to decide whether or not you wish to take part. If 
you decide to take part in this study, you are free to withdraw at any time without giving 
reasons for your decision and your refusal to participate will not affect your relationship 
with any of the researchers.  
 
This consent form may contain words that you do not understand.  Please ask the study 
staff to explain any words or information that you do not clearly understand. You may 
ask as many questions as you need to understand what the study involves.  Please feel 
free to discuss this with your family, friends or family physician. 
 
STUDY PURPOSE 
The purpose of this proposed research study is to determine the effect of consuming a 
carbohydrate (CHO) beverage during moderate intensity exercise on the performance 
outcomes, fuel use and blood glucose levels of athletes with a SCI. 
                                                                                         
STUDY PROCEDURES: If you agree to participate in the study, the following things 
will occur: 
 
The study will take place over three separate visits to the testing site. Each visit will take 
between 120 to 150 minutes. The first visit will involve completion of two documents. 
You will be asked to complete a participant history form that will let the researcher 
know some background information about your current medical status. You will also be 
asked to complete a physical activity readiness questionnaire (PAR-Q) that will let the 
researchers know whether participation in fitness testing is an acceptable thing for you, 
based on your current health status. Once both of these questionnaires are completed and 
approved we can then carry on with the remainder of the study. 
 
Collection of anthropometric data; body mass, height, skinfolds, and dual-energy x-ray 
absorptiometry (DXA) will also take place during the first visit. The body mass will be 
taken with a platform scale that measures to the 0.05 of a kilogram; height will be 
measured with you, the participants in a supine position (measured to the nearest 
centimetre). Skinfold measures will be taken from four sites on the right side of the 
body; specifically, biceps, triceps, suprailiac, and subscapular. Each site will be 
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 measured 3 times and the mean score will be used for analysis. A technician will carry 
out a DXA scan. The scan is a non-invasive test, which provides precise measurements 
of bone density, lean tissue mass, and total and regional body fat. The DXA unit uses 
very low dose x-rays of two different levels to distinguish between bone and soft tissue. 
DXA has been used to assess the body composition of athletes with SCI in previous 
research. 
 
The first visit will also include a fitness test, a VO2max test, which tests your aerobic 
fitness. Your aerobic fitness is your body’s capability to deliver oxygen to your working 
muscles while you are exercising on a stationary wheelchair roller- added in (indoor 
200m track- removed). Removed-(Your aerobic fitness will be measured using an 
adapted Leger and Boucher test. Pylons will be used to mark off every 50 meters around 
the track) Following test instructions and warm up, you will be asked to propel your 
wheelchair on the roller at increasing speeds until you are not able to go any faster. The 
VO2 protocol will start at an initial speed of 4km/ hour for 1 minute and then increase by 
1 km/hour every minute until exhaustion is noted. The pylons will be used as speed 
markers(removed). During the test you will breath into a mouthpiece so that the gas 
composition of your breath can be determined. The exercise test itself will take 
approximately 10 to 15 minutes but please allow for an hour to become familiar with the 
procedures and prepare for the test. 
After the completion of the exercise test you will be provided with detailed instruction 
on the completion of a 3-day food and activity log. By completing the 3-day log, the 
researchers can determine your average nutrient intake and activity patterns. The 3-day 
food and activity log will also be used as a guide between your second and third visits so 
that your food intake and activity patterns are consistent before each trial. 
The female participants will be asked about their menstrual cycle because different 
stages of menstruation can impact the way the body uses energy during exercise. To 
account for this factor, the female participants will be tested at predetermined times 
during their menstrual cycle. 
 
A research assistant otherwise not involved with the research project will give you a 
number. That number code system will be kept until the completion of data collection. 
The participants will be separated by gender and then each gender will be placed into 
two groups by random selection (i.e. by chance by a computer) under double blind 
conditions. The term double-blind conditions means that neither the research participants 
nor the research team will know which treatment the research participant is receiving, 
but that information will be made available in the event of a medical emergency. This 
method will be used to ensure that the gender distribution is equal between both groups. 
Half of the group (8 participants) will receive the treatment first and the other half (8 
participants) will receive the placebo first. Group 1 will receive the treatment beverage 
during exercise trial #1 and group 2 will receive the treatment beverage during exercise 
trial #2. You are doing the exercise trial once with the treatment beverage and once with 
the placebo beverage so that we can compare the differences between your two trials.  
 
 
All the participants will complete the same exercise and performance trial. The exercise 
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 and performance trial will be conducted on a stationary wheelchair roller (removed-
200m indoor track). You will be seated in your own racing and/or competition 
wheelchairs. The exercise trial is 1 hour at 65% VO2 max followed immediately by a 30-
minute performance trial in which distance covered (km) will be measured. During the 
30-minute performance trial you will be encouraged to cover as much distance as 
possible. The distance will be measured by a digital bike computer. During the exercise 
trial you will be asked to rate your level of exertion using Borg’s scale of rate of 
perceived exertion (RPE). This scale will be given to you at 20, 40, 60 minute mark of 
the 65% VO2 max exercise trial and at the completion of the 30-minute performance trial. 
 
After both of the 65% VO2 max exercise trials you will be required to perform a 5 second 
maximal contraction of your triceps muscle while the electric activity from your muscles 
is assessed. This assessment will involve the placement of electrode "stickers" on the 
skin over your triceps muscle and a computer wired to the electrodes will measure the 
electrical activity. This is to determine your nervous system's ability to activate your 
muscles. 
The two exercise trials will be held seven days apart. A research assistant, not otherwise 
involved in the study will measure the treatment and placebo powders to ensure that 
neither the researcher nor the participants will be aware of the beverage composition. 
The treatment beverage will be 200ml of an 8% CHO (8 grams of CHO per 100ml of 
water) ingested every 15 minutes during the 1 hour trial (at the 15, 30, 45, 60 minute 
mark); for a total of 64 grams of CHO. The placebo beverage will be the same color and 
contain a non-caloric sweetener.   
 
During the test you will breath into a mouthpiece so that the gas composition of your 
breath can be determined. Heart rate will also be monitored throughout the trial used a 
heart rate monitor. Blood glucose and blood lactate will be measured 10 minutes before 
the exercise trial and every 20 minutes during the hour at 65% VO2 max. Blood glucose 
will be analysed using a portable glucometer. A finger will be pricked and a drop of 
blood (0.6 microlitre) is then put on the test strip. The blood glucose meters and testing 
strips were selected because they are portable and only require small blood sample of 0.6 
µL. Blood lactate will be analysed by an AccusportTM Portable Lactate Analyzer. During 
the 30-minute performance trial blood samples will not be taken. Immediately after the 
30-minute performance trial and at 2, 5, and at 10 minutes post blood samples will be 
taken and analysed for glucose and lactate levels. 
 
 
BENEFITS 
If you choose to participate in this study, there may or may not be direct benefits to you. 
By participating in this study you will have the opportunity to gain information about 
your current body composition, dietary intake patterns, and fitness level. Also, it is 
possible that with the carbohydrate feeding your aerobic training will improve. These 
benefits, however, are not guaranteed.  
 
RISKS AND DISCOMFORTS 
While on this study, you may experience some discomfort due to the ingestion of the 
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 treatment beverages during the exercise trials. The exercise tests may cause you some 
discomfort because they will be performed to exhaustion. Injuries that may result 
include: muscle pulls, strains and or cramps, but this will be minimized by having you 
perform a proper warm up before the exercise tests. There is a possibility that you will 
feel muscle or joint soreness in the days following your exercise testing. 
 
There may be unknown or unforeseen risks during the study or after the study is 
completed. 
COST AND REIMBURSEMENTS 
There will be no cost to you for your participation in this study. You will not be charged 
for any research procedures. There will be no reimbursements for time commitments or 
pocket expenses such as transportation. 
 
RESEARCH-RELATED INJURY  
In the case of a medical emergency related to the study, you should seek immediate care 
and, as soon as possible, notify the study doctor. Necessary medical treatment will be 
made available at no cost to you. By signing this document, you do not waive any of 
your legal rights. 
 
 
CONFIDENTIALITY 
While absolute confidentiality cannot be guaranteed, every effort to make certain that 
your participation in this study, and information gathered during the study period will be 
kept confidential will be made. The research staff will do everything possible to keep 
your personal information confidential. Your name will not be used at all in the study 
records. Instead, a special number (which may include your initials and date of birth but 
not your name or address) will be used. All data and information regarding the study 
will be kept together, locked in a cabinet in the College of Kinesiology for a period of 
twenty-five years, in the care of the principle investigator, Dr. Carol Rodgers. All 
reporting of data in presentations and /or publication format will be done in aggregate 
form and will not refer directly to individual data.  
  
  
VOLUNTARY WITHDRAWAL FROM THE STUDY 
If you do decide to take part in this study, you are still free to withdraw at any time and 
without giving reasons for your decision. There will be no penalty or loss of benefits to 
which you are otherwise entitled, and your future medical care will not be affected. If 
you are a student at the University of Saskatchewan, refusal to participate or withdrawal 
from the study will not affect your academic standing or relationship with University 
instructors. 
 
If you choose to enter the study and then decide to withdraw at a later time, all data 
collected about you during enrolment in the study will be retained for analysis up to the 
point of your withdrawal. 
111 
 
  
CONTACT INFORMATION 
 
If you have questions concerning the study you can contact Dr. Carol Rodgers (principle 
investigator) at 306-966-1061 or Heather Hynes (student researcher) at 306-249-0171 
 
If you have questions about your rights as a research subject, you can contact the Chair 
of Biomedical Research Ethics Board, c/o Ethics Office, University of Saskatchewan, at 
306-966-4053. 
 
We will advise you of any new information that will have bearing on your decision to 
continue in this study. 
 
This study has been reviewed and approved on ethical grounds by the University of 
Saskatchewan Biomedical Research Ethics Board. The Research Ethics Board reviews 
human research studies. It protects the rights and welfare of the people taking part in 
those studies.   
 
CONSENT TO PARTICIPATE  
 
By signing below, I acknowledge that I have read or have had this read to me and that I 
understand the research subject information, the study procedures, and the consent form. 
I understand that my participation in this study is voluntary and that we can withdraw 
from the study at any time without penalty. I was given sufficient time to think about it. I 
had the opportunity to ask questions and have received satisfactory answers to all of my 
questions. I have received a copy of the consent form for my own purposes. 
 
By signing this document I do not waive any of my legal rights. I will be given a signed 
copy of this consent form. 
 
Participant’s signature:_______________________________ 
Date:_______________________. 
 
 
 
Researcher’s signature:________________________________ 
Date:______________________. 
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 Appendix III 
Participant History Form  
Name: _______________________           
Date of Birth:____________________ 
Gender:________________________ 
Sport Classification:__________________________ 
Height:__________________________ 
Current Bodyweight:_________________________ 
   
Please answer the following questions: 
 
History of present injury: 
 
1. Please state the level of your spinal cord injury (example: T12, T5, or Spina 
Bifida): 
___________________________________________________________ 
 
2. Please state the number of years since your spinal cord injury: 
___________________________________________________________ 
 
3. Please state if you currently have any current complications due to your spinal 
cord injury: ___________________________________________ 
__________________________________________________________ 
 
Medications & Supplements: 
 
4. Are you currently taking any supplements (vitamin, mineral, herbs, etc.)? 
Yes/No 
a. If Yes, please state with supplements: _____________________ 
_______________________________________________________ 
 
5. Are you currently taking any medications? Yes/No 
a.  If Yes, please state which medications:______________________ 
________________________________________________________ 
 
Sport Involvement: 
 
Please state the number of years that you have been involved in sport and which sport(s) 
you have participated in: _____________________________________ 
_______________________________________________________________________
_________________________________________________________ 
 
Thank you. 
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 Appendix IV 
 
Instructions for Documenting Food, Fluid & Activity Recording Forms 
 
Name:______________________________ 
Dates to Keep Your Food & Fluid Records Are:______________________________ 
Competitive Sport (e.g. athletics):_________________________________  
Competitive Event (e.g. 800 m):__________________________________ 
 
1. Record your food and fluid intake for each of the 3 days.  
 
2. Record all of your training and activities conducted for each of the 3 days. 
 
3. Provide as many details about your food & fluid choices as possible. For example, if 
you had a sandwich please indicate what was in the sandwich, i.e.1 teaspoon 
mustard, 1 lettuce leaf, ½ tomato, 60 grams oven roasted turkey, 2 slices whole 
wheat bread, etc.; OR, if you ate a bowl of cereal, was it dry cereal or did you add 
milk, and if so, what kind of milk, 1%, skim, etc.? What was the size of your bowl?  
 
4. Initially serve yourself your usual food/fluid portion and then measure the food or 
fluid item to the best or your ability. 
 
5. Indicate the precise volume of a beverage, rather than stating “one glass”, indicate 
the volume- 250ml, 500ml, etc. 
 
6. Record how a food was prepared, e.g. pan fried, barbecued, broiled, boiled, steamed, 
oils added, etc. 
 
7. Did you add any condiments (i.e. catsup, salad dressing, butter, etc.) to your foods? 
 
8. Wherever possible record the commercial product names, e.g., Eggo plain frozen 
waffles, Quaker Plain Instant Oatmeal, Gatorade powder, etc. 
 
9. Don’t forget to record all fluids consumed from sport drinks and coffee to water and 
1% milk. 
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FOOD, FLUID & ACTIVITY RECORDING FORM—EXAMPLE 
 
Name:______________________________                       Date:__________________ 
Training activity for this day: 
 
Activity type:     Aerobic training     Strength training     Mixed aerobic and 
strength training 
Other type of 
Activity:___________________________________________________________  
Activity intensity:    Low        Medium      High     
Activity duration (hours):  _________        
When did you train today:_______________________________________________ 
 
Time 
Food / Fluid / Food Brand Names 
Amount Size 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 Appendix V EXERCISE TRIAL & PERFORMANCE TRIAL 
 
 
1
1
9
 
 
Heart rate- monitored continuously 
 Metabolic Cart – monitored for 5-minute time periods during the 60-minute exercise trial and continuous monitoring during the 30-
minute performance trial.  
 
Performance measures  
 
 
 
 
    
                 0 min     15min             30 min               45 min                      60 min 
 
CHO 
controlled 
meal 3 
hours prior 
30-minute 
Performance Trial  
 
 
 
1 hour at 65% VO2peak 
 200 ml beverage provided at 15, 30, 45, 60-min mark 
 
      Blood glucose and blood lactate immediately post, and 2, 5, 10-min post performance trial 
 
     Blood glucose and Lactate at pre-exercise, 20, 40, 60-min mark 
 
     RPE at 20, 40, 60-min mark and at the completion of the performance trial 
 
 
 
 
   
 
 
 
 
 
 
 
               
Appendix VI 
Pre-Exercise Meals: Goal intake 3 hours prior to the exercise trial is 1 to 4 grams 
carbohydrate (CHO)/kg Bodyweight (BW) ** amount set at 2g·kg-1 BW 
IMPORTANT- After your meal do not consume any food or fluids (with calories) 
 
1. Current BW of 50 to 60 Kg: 100 to 120 grams CHO 
Meal: 500ml Fruit juice (56 g) + 2 slices bread (28 g) + 1 Tbsp Jam (14 g) + 1 
Tbsp peanut butter (3g) 
 
2. Current BW of 61 to 70 Kg: 122 to 140 grams CHO 
Meal: 500ml Fruit juice (56g) + 2 slices bread (28 g) + 1 Tbsp Jam (14 g) + 1 
Tbsp peanut butter (3 g) + 1 banana (27 g)  
 
3. Current BW of 71 to 80 kg: 142 to 160 grams CHO 
Meal: 500ml Fruit juice (56g) + 3 slices bread (42 g) + 2 Tbsp Jam (28 g) + 1 
Tbsp peanut butter (3 g) + 1 banana (27 g)  
 
4. Current BW of 90 to 100 kg: 180 to 200 grams CHO 
Meal: 500ml Fruit juice (56g) + 4 slices bread (56 g) + 2 Tbsp Jam (28 g) + 1 
Tbsp peanut butter (3 g) + 1 banana (27 g) + ½ cup applesauce (sweetened) 
(27 g) 
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Appendix VII 
 
Results- Distance Values (km) and % VO2peak Values 
 
 
Total distance covered during 60-minute exercise trial 
Participant 
code 
CHO beverage trial (km) Placebo beverage trial (km) 
1 9.44 8.69 
2 8.06 8.53 
3 7.13 7.12 
4 12.32 12.10 
5 8.75 8.48 
6 6.90 6.62 
7 6.58 6.50 
8 7.21 7.12 
Mean ± SD 8.29 ± 1.89 8.14 ± 1.83 
Individual results presented, means ± SD (n=8). Carbohydrates (CHO). 
 
 
%VO2peak for the 60-minute exercise trial 
# code % VO2 peak CHO 
Trial 
% VO2 peak Placebo 
Trial 
1 57 55 
2 48 49 
3 66 66 
4 52 59 
5 57 58 
6 64 62 
7 64 61 
8 51 47 
Mean ± 
SD 57 ± 6 57 ± 7 
Individual results presented, means ± SD (n=8). 
 
 
 
 
 
 
 
 
 
 
 
121 
 
  
 
 
%VO2peak for the 30-minute performance trial 
# code % VO2 peak CHO Trial % VO2 peak Placebo Trial 
1 78 79 
2 68 77 
3 78 76 
4 65 77 
5 95 88 
6 121 100 
7 79 80 
8 56 51 
Mean ± 
SD 80 ± 20 79 ± 14 
Individual results presented, means ± SD (n=8). 
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 Appendix VIII 
 
Participant 1: Male, 45yrs, SCI T4, 79 Kg, 165cm 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 CHO 9.4  9.4  12.3  6.2  12.2  16.1  
2 Placebo 8.7 8.6  12.3  6.4 12.8  16.1  
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
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Participant 2: Male, 28 yrs, CP, 72 Kg, 168.5 cm 
 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 CHO 8.1 8 11.7 5.3 10.4 17.9 
2 Placebo 8.53 8 12 5.5 11 19.5 
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
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Participant 3: Female, 27 yrs, SCI T1, 53 Kg, 151 cm 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 CHO 7.1 7.1 10.3 4.35 8.6 11.6 
2 Placebo 7.1 7.1 10.5 4.41 8.8 10.9 
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
 
Athlete overheated during trial #2 with the placebo beverage at 12 minutes into 
performance trial. 
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 Participant 4: Male, 24 yrs, SCI L1, 93 Kg, 180 cm 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 Placebo 12.1 11.7 14.5 7.28 14.4 16.7 
2 CHO 12.3 12.3 14.7 7.20 14.4 17.4 
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
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 Participant 5: Male, 43 yrs, SCI T3, 84 Kg, 189 cm 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 Placebo 8.48 8.4 10.5 6.40 12.8 15.5 
2 CHO 8.75 8.7 11.9 6.42 12.8 16.1 
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
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Participant 6: Male, 44 yrs, SCI C6, 68 Kg, 182 cm 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 Placebo 6.62 6.60 11.3 4.39 11.4 15.8 
2 CHO  6.90 6.90 9.1 4.56 12.0 16.6 
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
Both performance trials were 22:33.00 minutes in duration. The participant could not 
complete the 30-minute trial. 
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 Participant 7: Male, 41 yrs, SCI C5-6, 90.7 Kg, 188 cm 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 Placebo 6.50 6.5 11.4 4.29 8.4 13.0 
2 CHO  6.58 6.5 10.8 4.27 8.4 10.9 
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
 
Participant comment at completion of exercise trial #1 with the placebo beverage was an 
overall body fatigue. 
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Participant 8: Female, 34 yrs, SCI T12-L1, 88.6 Kg, 185.4 cm 
 
Distance Results: 
Trial # Drink # 
60-min 
Distance 
(km) 
Average 
Speed 
(km·h-1) 
Max 
Speed 
(km·h-1) 
P-Distance 
(km) 
P-Avs 
(km·h-1) 
P-Mxs 
(km·h-1) 
1 CHO 7.21 7.2 8.9 3.80 7.6 8.8 
2 Placebo 7.12 7.2 8.7 3.83 7.6 9.6 
           30-min Performance trial (P), Average Speed (Avs), Maximal speed (Mxs) 
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